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Introduction 
1 INTRODUCTION 
 
1.1 Structure and Functions of Tetrapyrroles 
 
Tetrapyrroles are nearly present ubiquitous in all organisms. They are involved in 
the eukaryotic as well as in prokaryotic cell physiology. The basic structure 
consists of four pyrrole rings which are either linked to a ring system or a linear 
molecule. The universal basic structure of the cyclic tetrapyrroles is the porphyrin 
ring whose pyrrole derivates are connected by four methine bridges. The four 
pyrrole rings are denoted A, B, C and D in a clockwise direction. The carbon and 
nitrogen atoms are serially numbered with C1-C20 and N21-N24 (Figure 1.1). The 
α-position denotes the carbons which are close to the nitrogen atoms. The 
carbons which form the methine bridges are in meso-position and the remaining 
carbons are in β-position (Chadwick and Ackrill, 1994; Jordan, 1991; Warren and 
Smith, 2008). 
 
Figure 1.1: Basic structure of all cyclic tetrapyrroles, the porphyrin ring. 
The four pyrrole rings are denoted A, B, C and D in a clockwise direction. The carbon and nitrogen 
atoms are serially numbered with C1-C20 and N21-N24. The α-position denotes the carbons which 
are close to the nitrogen atoms. The carbons which form the methine bridges are in meso-position 
and the remaining carbons are in β-position.  
 
 
Cyclic tetrapyrroles discriminate in their variable oxidation state of their ring 
system, the nature of the chelated metal ion and the ring substituents at the  
β-position of the pyrrole rings. The centred nitrogen atoms are able to chelate 
different metal ions like iron, magnesium, cobalt or nickel (Frankenberg et al., 
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2003; Heinemann et al., 2008; Layer et al., 2010). Because of their conjugated  
π-electron system tetrapyrroles are able to absorb different parts of the visual light. 
For example, haem is responsible for the red colour in blood or chlorophyll colours 
plants green. Linear tetrapyrroles derive from cleavage of cyclic tetrapyrroles. 
They are divided into bile pigments, phycobilins and degradation products of the 
macrocycles (Dammeyer and Frankenberg-Dinkel, 2008). Based on their 
characteristics the tetrapyrroles are divided into eight classes: haem (Munro et al., 
2008; Rodgers, 1999), chlorophyll, bacteriochlorophyll (Beale, 1999; Vavilin and 
Vermaas, 2002), corrinoids, sirohaem (Raux et al., 2003), haem d1 (Chang and 
Wu, 1986; Chang, 1994), cofactor F430 (Thauer and Bonacker, 1994) and open-
chain tetrapyrroles. Because of the leak of the fourth carbon bridge (C20, see 
Figure 1.1) the corrinoides form an exception (Battersby, 2000; O'Brian and 
Thony-Meyer, 2002). All cyclic tetrapyrroles are derived from the common 
precursor uroporphyrinogen III (Figure 1.2).  
Tetrapyrroles play vital roles in various biological processes. Magnesium 
containing chlorophylls and bacteriochlorophylls serve as essential 
macromolecules in photosynthesis by absorbing light and transferring light energy 
or electrons to other molecules (Beale, 1999). Haemoglobin and myoglobin utilise 
iron-chelating haem for oxygen and carbon dioxide transport. Moreover, haem is 
found in cytochromes and enzymes as prosthetic group where they are involved in 
electron transport and enzymatic reactions (Panek and O'Brian, 2002). The iron- 
chelating sirohaem is a cofactor involved in assimilatory nitrite or sulfite reduction 
(Chang, 1994; Raux et al., 2003). Corrinoids, such as the cobalt chelating 
vitamin B12, are involved in radical-depended nucleotide reduction and in methyl 
transfer (Warren and Smith, 2008). The nickel chelating coenzyme F430 takes part 
in the methanogenesis in archaea (Friedmann et al., 1990; Thauer and Bonacker, 
1994). Linear tetrapyrroles do not contain a tightly bound metal ion. They can be 
found as bile pigments in humans and chromophores, as parts of the plant 
photoreceptors and in cyanobacteria (Frankenberg and Lagarias, 2003). The 
diversity and wide dispersal of this class of cofactors implies the importance in 
nature. In eukaryotes the tetrapyrrole biosynthesis is restricted to haem, sirohaem, 
chlorophyll and biline formation. Prokaryotes are additionally able to synthesise 
corrinoids, coenzyme F430 and haem d1 (Jahn et al., 1996; Vavilin and Vermaas, 
2002). 
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Figure 1.2: Representative structures of the eight tetrapyrrole classes and their common 
precursor uroporphyrinogen III. 
 
Tetrapyrroles are divided into eight classes: haem, chlorophyll, bacteriochlorophyll, corrinoids, 
sirohaem, haem d1, cofactor F430 and open-chain tetrapyrroles. All cyclic tetrapyrroles are derived 
from the common precursor uroporphyrinogen III. Linear tetrapyrroles result from the cleavage of 
cyclic tetrapyrroles. 
 
 
1.2 Tetrapyrrole Biosynthesis  
 
The tetrapyrrole biosynthesis is a highly conserved mechanism which is controlled 
by different regulation mechanisms in the cell. 5-aminolaevulinic acid (ALA) is the 
common precursor for all tetrapyrroles, which contains all carbon and nitrogen 
atoms required to build the porphyrin macrocycle. The major branching point 
occurs after the formation of the first cyclic tetrapyrrole, uroporphyrinogen III. This 
is either converted into protoporphyrin IX or precorrin-2. Protoporphyrin IX is the 
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precursor for so called porphyrins like haem, chlorophyll and bacteriochlorophyll, 
which are characterised by their completely conjugated planar ring system, while 
precorrin-2 serves as basic frame for porphinoids like sirohaem, haem d1, 
coenzyme F430 and corrinoids (Warren and Smith, 2008). 
 
 
1.2.1 Two Pathways for the Biosynthesis of 5-Aminolaevulinic Acid 
 
The first step in the tetrapyrrole biosynthesis in all organisms is the formation of  
5-aminolaevulinic acid (ALA), which is synthesised in nature in two unrelated 
pathways.  
Vertebrates, yeasts and α-proteobacteria form ALA by condensation of glycine and 
succinyl-CoA with subsequently release of carbon dioxide and coenzyme A (CoA; 
Figure 1.3). This reaction is catalysed by the pyridoxal-5’-phosphate-dependent  
5-aminolaevulinic acid synthase (ALAS; encoded by hemA; EC 2.3.1.37). The 
pyridoxal-5’-phosphate is covalently linked to an essential active site lysine, 
forming an internal aldimine. The reaction starts when glycine binds to the active 
site and forms an external aldimine with the pyridoxal-5’-phosphate cofactor. This 
is followed by the stereo-specific abstraction of the pro-R proton of glycine, leading 
to the formation of a quinonoid intermediate. This condenses with succinyl-CoA to 
form a 2-amino-3-ketoadipate intermediate by coenzyme A and CO2 release. Then 
a proton replaces the glycine-derived carboxyl group and ALA is released as the 
internal aldimine is restored (Hunter et al., 2007; Hunter and Ferreira, 2009). 
 
 
Figure 1.3: Shemin way: formation of 5-aminolaevulinic acid. 
Biosynthesis of 5-aminolaevulinic acid in vertebrates, yeasts and α-proteobacteria takes place via 
condensation of glycine and succinyl-CoA by 5-aminolaevulinic acid synthase (hemA).  
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The catalytic reaction was named after its discoverer Shemin. In 1945 Shemin and 
Rittenberg reported for the first time that the nitrogen atom originates from glycine 
in haem (Shemin and Rittenberg, 1945, 1946). Therefore, Shemin himself 
ingested 15N-labled glycine over a period of three days and took regularly blood 
samples. Based on his results, Shemin concluded that porphyrin is synthesised in 
vivo from glycine and other compounds. Years later the Shemin group identified 
succinyl-CoA as the second source of carbon atoms in haem (Shemin and Kumin, 
1952). Finally, ALA was suggested to be the source of all atoms of protoporphyrin 
(Kikuchi et al., 1958; Shemin and Russel, 1953).  
Plants, archaea and the vast majority of bacteria use the so called C5-way. Here, 
glutamyl-tRNA serves as initial substrate. Then, two enzymatic steps are required 
to form ALA (Figure 1.4). 
 
 
Figure 1.4: C-5 way: formation of 5-aminolaevulinic acid. 
Glutamyl-tRNA reductase (GluTR) reduces glutamyl-tRNA by use of NADPH under tRNAGlu release 
to glutamate-1-semialdehyde (GSA). GSA is converted to 5-aminolaevulinic acid (ALA) in a 
pyridoxal-5’-phosphate dependent reaction by glutamate-1-semialdehyde-2,1-aminomutase 
(GSAM). 
 
 
The glutamyl-tRNA reductase (GluTR, encoded by hemA; EC 6.1.1.17) uses the 
glutamylated tRNA as substrate in an NADPH-depended reaction. The chemical 
high reactive glutamate-1-semialdehyde (GSA) is emerged from this reduction, 
while tRNAGlu is released. Subsequently, GSA is converted to ALA in a pyridoxal-
5’-phosphate (PLP) dependent transamination reaction by the glutamate-1-
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semialdehyde-2,1-aminomutase (GSAM, encoded by hemL; EC 5.4.3.8; Beale 
and Castelfranco, 1973; Jahn et al., 1992). GSA is a highly reactive aldehyde. For 
that reason an earlier proposal suggested that GluTR and GSAM form a complex, 
which is in line with the structural complementary of the two enzymes (Moser et 
al., 2002) and was finally proven to exist in vivo (Luer et al., 2005). 
 
 
1.2.2 Conversion of 5-Aminolaevulinic Acid to Haem 
 
In the first common step in the biosynthesis 
two ALA molecules are asymmetric 
condensed to porphobilinogen by 
porphobilinogen synthase (PBGS; 
encoded by hemB; EC 4.2.1.24), which 
uses metal ion as cofactors. In different 
organisms variable cations are chelated for 
example zinc, magnesium or potassium 
(Frankenberg et al., 1999a; Frankenberg et 
al., 1999b; Jaffe, 2003; Shoolingin-Jordan 
et al., 2002). By elimination of NH3 the 
porphobilinogen deaminase (PBGD; 
encoded by hemC; EC 4.3.1.8) links four 
porphobilinogen molecules to the instable 
linear pre-uroporphyrinogen (Figure 1.5; 
Louie et al., 1992; Warren and Jordan, 
1988). Porphobilinogen deaminase 
contains dipyrromethane, an unusual 
cofactor consisting of two molecules of 
porphobilinogen. Dipyrromethane is 
covalently attached to the enzyme and 
serves as the starting point of 
tetramerisation of porphobilinogen without 
being integrated into the final product (Jordan and Warren, 1987; Jordan, 1994a). 
Subsequently the uroporphyrinogen III synthase (UROS; encoded by hemD; EC 
Figure 1.5: Conversion of  
5-aminolaevulinic acid (ALA) into pre-
uroporphyrinogen  
Porphobilinogen synthase (PBGS) 
catalyses the formation of por-
phobilinogen (PBG) by asymmetric 
condensation of two 5-aminolaevulinic 
acid (ALA) molecules. Four PBG 
molecules are linked to the unstable 
linear pre-uroporphyrinogen by 
porphobilinogen deaminase (PBGD) via 
NH3 elimination. A = acetate side chain; 
P = propionate side chain. 
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4.2.1.75) forms the common cyclic 
precursor uroporphyrinogen III by 
condensation. At this point the important 
step is the inverting of the tetrapyrrole D 
ring via a spiro-mechanism with spiro-
pyrrolenine as an intermediate to form an 
asymmetric tetrapyrrole (Chadwick and 
Ackrill, 1994). Then the biosynthesis of the 
various tetrapyrroles divides. On the one 
hand uroporphyrinogen III is methylated at 
C2 and C7 by uroporphyrin III C-
methyltransferase (EC 2.1.1.107) to form 
dihydrosirohydrochlorin (precorrin-2) which 
is the precursor of corrinoids, sirohaem, 
haem d1 and coenzyme F430 (Jahn et al., 
1996). On the other hand haem, 
chlorophyll and bacteriochlorophyll are 
formed. The next step in the haem and 
chlorophyll pathway is the decarboxylation 
of four acetate side chains to methyl 
groups by uroporphyrinogen III 
decarboxylase (UROD; encoded by hemE; 
EC 4.1.1.37; Akhtar, 1994). The 
decarboxylation proceeds in an ordered 
manner beginning with the acetate chain of 
ring D, followed by A, B and finally C 
(Figure 1.6). Subsequently, the originated 
coproporphyrinogen III is modified by 
converting the propionate groups on ring A 
and B into vinyl side chains by 
coproporphyrinogen III oxidase (CPO; encoded by hemN or hemF; EC 1.3.3.3). 
This reaction can be catalysed by two structurally non-related enzymes: the 
oxygen-dependent enzyme HemF, which uses molecular oxygen as an electron 
acceptor and the oxygen-independent “radical SAM”-enzyme HemN, which utilises 
Figure 1.6: First steps of haem 
formation  
Uroporphyrinogen III synthase (UROS) 
forms the first asymmetric cyclic 
tetrapyrrole uroporphyrinogen III by 
inverting the D ring. At this branching 
point in the biosynthesis uro-
porphyrinogen III is either converted into 
precorrin-2 the precursor for sirohaem, 
vitamin B12, haem d1 and coenzyme F430 
or into coproporphyrinogen III via 
converting the acetate chains into methyl 
chains by uro-porphyrinogen III 
decarboxylase (UROD). A = acetate side 
chain; P = propionate side chain; M = 
methyl side chain. 
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alternative electron acceptors (Breckau et 
al., 2003; Layer et al., 2002). The side 
chain modification is completed with the 
formed protoporphyrinogen IX.  The next 
enzyme, protoporphyrinogen IX oxidase 
(PPO; encoded by hemG and hemY; EC 
1.3.3.4), catalyses the oxidation to 
protoporphyrin IX, which requires the 
elimination of six electrons and results in 
the formation of a system of completely 
conjugated double bonds. Like CPO two 
structurally non related enzymes exist. 
Oxygen-dependent PPO (HemY) uses a 
flavin cofactor and molecular oxygen as an 
terminal electron acceptor  (Hansson and 
Hederstedt, 1994; Koch et al., 2004), 
whereas oxygen-independent PPO 
(HemG) was shown to transport the 
electrons to anaerobic respiratory chains 
with alternative terminal electron acceptors 
such as nitrate or fumarate (Jacobs and 
Jacobs, 1975, 1976).  Recently, studies 
revealed that under aerobic conditions this 
HemG transfers the abstracted electrons 
via ubiquinone, cytochrome bo3 and 
cytochrome bd to oxygen. While under 
anaerobic conditions the electrons are 
transferred via menaquinone, fumarate and nitrate reductase (Möbius et al., 2010). 
Here is the next branching point in the biosynthesis. By inserting iron, which is 
catalysed by the ferrochelatase (FC; encoded by hemH; EC 4.99.1.1), 
protohaem IX (haem b) is formed, whereof all haems derive from. By chelating a 
magnesium ion into the protoporphyrin IX by magnesiumchelatase (MC), the 
synthesis of chlorophyll and bacteriochlorophyll is initiated (Figure 1.7; Jordan, 
1994b; Jordan, 1991). 
Figure 1.7: Last steps of haem 
formation 
Converting the propionate groups into 
vinyl groups by coproporphyrinogen III 
oxidase (CPO) is the last side chain 
modification step. The completely 
modified tetrapyrrole protoporphyrinogen 
IX is finally oxidised into protoporphyrin 
IX by protoporphyrinogen IX oxidase 
(PPO). On the one hand haem b is 
formed via inverting a Fe2+ by 
ferrochelatase (FC) on the other hand the 
precursor for chlorophyll and 
bacteriochlorophyll is formed via inverting 
Mg2+ by magnesium-chelatase (MC). P = 
propionate side chain; V = vinyl side 
chain; M = methyl side chain 
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The variety of functions fulfilled by tetrapyrroles underscores their importance in 
nature, and explains the extensive effect of disorders in tetrapyrrole anabolism. 
These disorders cause toxic stress symptoms and cellular damage via 
peroxidation of membrane lipids (Meissner et al., 1996). In humans, the rare 
heterogeneous metabolic disorders are commonly known as porphyrias (see 
chapter 1.7). However, there are still open questions, for example how do the 
enzymes cooperate in vivo to prevent solvent exposure and accumulation of 
biosynthesis intermediates, although they are located in different compartments in 
the cell (inner mitochondrial membrane, cytosol or chloroplast). For the two last 
enzymes in haem biosynthesis, PPO and FC, a complex formation was shown in 
vitro by co-immunoprecipitation and in vivo via immunogold labelling and electron 
microscopy in Thermosynechococcus elongatus (Masoumi et al., 2008). The next 
chapter summarises the state-of-the-art knowledge about the enzymes used in 
this study. 
 
 
1.3 Porphobilinogen Synthase 
 
Porphobilinogen synthase (PBGS; or 5-aminolaevulinic acid dehydratase) is the 
first common enzyme in the tetrapyrrole biosynthesis. PBGS is encoded by the 
gene hemB and catalyses the asymmetric condensation of two molecules  
5-aminolaevulinic acid (ALA) via the release of two molecules water to form 
porphobilinogen (PBG). PBGS from various organisms has been investigated e.g. 
Escherichia coli (Erskine et al., 1999b), Pseudomonas aeruginosa (Frankenberg et 
al., 1999b), Homo sapiens (Breinig et al., 2003; Jaffe et al., 2001) and 
Saccharomyces cerevisiae (Erskine et al., 1999a). PBGSs share a high degree of 
sequence similarity. The most common active form is a homo-octamer with a 
molecular mass of 280’000-320’000. For all PBGSs a use of metal ion cofactors 
e.g. Zn2+ and/or Mg2+ have been described. During substrate recognition and 
substrate attachment the PBGS has to treat two identical molecules discretely to 
ensure defined asymmetric condensation at the catalysis (Shoolingin-Jordan and 
Cheung, 1999).  
Crystal structures of PBGS from various sources confirm the presence of two 
distinct binding sites for each ALA molecule, the so called A- and P-site. Thus, the 
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product molecules sites are discriminated into an A- and P-site. This depends on 
the two substrate molecules ALA according to which the acetate and propionate 
side chain, respectively, originate from. The synthesis of PBG requires a 
successive formation of a C-C bond and a C-N bond between the substrate 
molecules. For the PBGS from P. aeruginosa it was shown that the reaction is 
initiated by formation of Schiff base bonds between the two ALA substrate 
molecules and two conserved lysine residues in the active site (Figure 1.8). 
Inhibitor studies revealed that the Aldol condensation (C-C bond formation) of the 
two ALA substrate molecules is the first reaction step, followed by the Schiff base 
C-N bond (Frere et al., 2002; Frere et al., 2006).  
The recently discovered antibacterial compound alaremycin was isolated from the 
actinomycete Streptomyces sp. A012304 (Awa et al., 2005). Alaremycin 
structurally closely resembles ALA. PBGSs of Gram-positive and Gram-negative 
bacteria revealed alaremycin inhibition. Cocrystallisation of alaremycin and 
recombinant produced P. aeruginosa PBGS demonstrated that the active site is 
efficiently blocked. The results revealed that PBGS is a molecular target of 
alaremycin (Heinemann et al., 2010). 
 
 
Figure 1.8: Reaction mechanism of porphobilinogen synthase. 
Enzymatic reaction catalysed by P. aeruginosa porphobilinogen synthase (PBGS) during 
tetrapyrrole biosynthesis; two molecules of 5-aminolaevulinic acid (ALA) are condensed 
asymmetrically to form the first pyrrole porphobilinogen (PBG). Crystal structures of PBGS from 
various sources confirm the presence of two district binding sites for each ALA molecule, the so 
called A and P-site. Denotations of the substrate binding sites are ensued towards the occurred 
product side chains. This depends on the two substrate molecules ALA according to which the 
acetate and propionate side chain, respectively, originate from (modified after Frere et al., 2005). 
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1.4 Uroporphyrinogen III Synthase 
 
Uroporphyrinogen III synthase (UROS; formally uroporphyrinogen III cosynthase) 
was described by Bogorad and Granick in 1953 for the first time (Bogorad and 
Granick, 1953). UROS is encoded by the gene hemD and catalyses the fourth 
step in the tetrapyrrole biosynthesis. It was shown for the conversion of the 
monopyrrole porphobilinogen into the first cyclic tetrapyrrole uroporphyrinogen III 
(Uro’gen III) two enzymes porphobilinogen deaminase (PBGD), as well as UROS 
are required (Bogorad, 1958a, 1958b). PBGD catalyses the formation of the 
instable intermediate pre-uroporphyrinogen (Burton et al., 1979), which serves as 
substrate for the UROS (Jordan et al., 1979; Jordan and Berry, 1980). 
Uroporphyrinogen III synthases were isolated and characterised from several 
organisms: Euglena gracilis (Hart and Battersby, 1985), Bacillus subtilis (Stamford 
et al., 1995), Anacystis nidulans (Roessner et al., 2002), E. coli (Jordan et al., 
1988), H. sapiens (Mathews et al., 2001; Omata et al., 2004), Rattus sp. (Kohashi 
et al., 1984), Synechocystis sp. PCC 6803 (Kaneko et al., 1995), S. cerevisiae 
(Amillet and Labbe-Bois, 1995) and Arabidopsis thaliana (Tan et al., 2008), 
respectively. To date, the enzyme is shown to be a monomer in all examined 
organisms with an average size of 28’000 to 35’000, which contains no reversible 
bound cofactors or metal ions.  
In contrast to other enzymes of the tetrapyrrole biosynthesis UROS does not show 
a high amino acid sequence homology (Jahn et al., 1996). Since then, many 
controversial catalytic mechanisms have been postulated. Today it is assumed 
that it is an interlude between PBGD and UROS to prevent the release of pre-
uroporphyrinogen, which would spontaneously and irreversible cyclised to the 
symmetric toxic uroporphyrinogen I (uro’gen I; Battersby et al., 1979). This 
hypothesis is supported by the fact that the two encoding genes (hemC and 
hemD) are organised in the same operon in many so far examined bacteria. Thus, 
a coproduction of the enzymes are preventing the formation of uro’gen I 
(Figure 1.9; Jordan and Warren, 1987; Jordan and Woodcock, 1991). On the one 
hand uroporphyrinogen III methyltransferase would not be able to form the 
precursor dihydrosirohydrochlorin for corronoids, sirohaem, haem d1 and 
coenzyme F430. On the other hand coproporphyrinogen III, the precursor for haem, 
chlorophyll and bacteriochlorophyll, can not be formed by the 
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uroporphyrinogen III decarboxylase. Uro’gen I can be metabolised by 
uroporphyrinogen III decarboxylase but this leads to an accumulation of the toxic 
coproporphyrinogen I. To date, there is no evidence of substrate channelling or 
complex formation between PBGD and UROS in vivo as it was verified for the last 
two biosynthesis enzymes, protoporphyrinogen IX oxidase and ferrochelatase in 
T. elongatus (Masoumi et al., 2008).  
 
 
Figure 1.9: The spiro mechanism of the uroporphyrinogen III synthase. 
Pre-uroporphyrinogen is cyclised via an azafluvene and spiro intermediate to uroporphyrinogen III 
by uroporphyrinogen III synthase (UROS); at this the inversion of the D-pyrrole ring is important. 
Without UROS uroporphyrinogen III is non-enzymatically formed into the symmetric and toxic 
uroporphyrinogen I. A: acetyl side chain; P: propionate side chain (modified after Roessner et al., 
2002). 
 
 
In nature the enzymatic cyclisation reaction of pre-uroporphyrinogen to 
uroporphyrinogen III (Figure 1.9) requires an isomerisation of the D-pyrrole ring 
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(Battersby and Leeper, 1990). At first a carbo-cation (Azafulvene intermediate) is 
formed by water elimination from the pre-uroporphyrinogen. A so called spiro 
intermediate occurs by the conjunction of the A-pyrrole ring carbon C1 and the 
carbon C16 of the D-pyrrole ring. Finally, uroporphyrinogen III is formed by 
inversion of the electrophilic addition with a cleavage between the C- and  
D-pyrrole ring and a following electrophilic substitution. The intermediate stability is 
guaranteed via free electron pairs of the nitrogen atoms in the C- and D-pyrrole 
ring which can be shifted into the ring system (Battersby et al., 1978; Cassidy et 
al., 1996; Chadwick and Ackrill, 1994; Crockett et al., 1991). 
 
 
1.5 Uroporphyrinogen III Decarboxylase 
 
Uroporphyrinogen III decarboxylase (UROD) is a cytosolic enzyme which 
catalyses the conversion of uroporphyrinogen III to coproporphyrinogen III by 
decarboxylation of the four acetic side chains into methyl chains. In plants, 
bacteria and yeast, UROD must compete for uroporphyrinogen III with 
uroporphyrinogen III methylase, the first enzyme of the pathway to sirohaem and 
corrin biosynthesis. Both naturally occurring isomers of uroporphyrinogen (I & III) 
are substrates for UROD, but only coproporphyrinogen III can be ultimately 
converted to haem (Phillips and Kushner, 1999). There is a general interest in the 
enzyme since mutations in the corresponding gene cause the rare human disease 
porphyria cutanea tarda (Elder and Roberts, 1995).  
UROD from several organisms has been investigated e.g. 
Synechococcus elongatus PCC 7942 (Saito et al., 2008); E. gracilis Z (Juknat et 
al., 1989); Rhodobacter sphaeroides (Jones and Jordan, 1993); rat liver (Smith 
and Francis, 1979); S. cerevisiae (Felix and Brouillet, 1990); E. coli (Nishimura et 
al., 1993); B. subtilis (Fan et al., 2007; Hansson and Hederstedt, 1992); 
Plasmodium falciparum (Nagaraj et al., 2009); Nicotiana tabacum (Martins et al., 
2001a; Martins et al., 2001b); H. sapiens (de Verneuil et al., 1983; Phillips et al., 
1997; Romeo et al., 1986) and Gallus gallus (Seki et al., 1986). URODs subunits 
have a relative molecular weight of around 40’000. Except for human, tobacco and 
chicken URODs, whose structures reveal a homodimer, until now all others seem 
to be monomeric. To date all studies indicate that there is no requirement for 
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cofactors or prosthetic groups for enzymatic activity which mark UROD as a very 
unusual decarboxylase (de Verneuil et al., 1980; de Verneuil et al., 1983; Straka 
and Kushner, 1983). There are hypothetically 24 possible pathways between 
uroporphyrinogen III and coproporphyrinogen III involving up to 14 intermediates. 
Nevertheless, early studies revealed that at high substrate concentrations the 
decarboxylation sequence is random. However, at physiological substrate 
concentrations the reaction runs in a specific order starting at ring D followed in a 
clockwise direction with ring A, B and C. It has been demonstrated that the 
reaction is a biphasic process in which the first acetate group is removed at a 
faster rate than the remaining three (Jackson et al., 1976; Jones and Jordan, 
1993; Luo and Lim, 1993; Tomio et al., 1970). The reaction mechanism is hardly 
understood. Because of lack of a cofactor, the enzyme itself has to be the proton 
donor. Comparisons of the amino acid sequences reveal a 10 % identity and 33 % 
similarity with a highly conserved stretch of residues like proline, glycine, histidine 
and arginine in all to date examined species.  
The human structure shows many conserved residue clusters at the active site 
cleft including invariant amino acids like Arg37, Arg41, His339, Asp86, Tyr164 and 
Ser219 which probably function in substrate binding and catalysis (Whitby et al., 
1998). Inhibition, mutation and density-functional calculation studies exclude 
several amino acids and confirm that Asp86 or Arg37 play a direct role in catalysis 
(Silva and Ramos, 2005). The human dimer structure serves to make a deep cleft 
where the negative charged substrate is nestled in a lot of positively charged 
residues in the active centre. The crystal structure also indicates that the substrate 
and the intermediates are hydrogen bound to the enzyme by aspartate carboxyl 
oxygen linked to the pyrrole nitrogen. So it was proposed that Asp86 stabilises the 
pyrrole and the reactive Arg37, which is located in a very short distance to the 
pyrrole, successively protonates the pyrrole rings. To date no further biochemical 
attempts have been made to identify Arg37 or further amino acids as proton donor 
(Figure 1.10; Lewis and Wolfenden, 2008; Martins et al., 2001a; Martins et al., 
2001b; Phillips et al., 2003; Silva and Ramos, 2005; Whitby et al., 1998; Wyckoff 
et al., 1996). Recently, studies indicate that each UROD subunit is able to function 
independent as an active catalytically site and is able to perform all four 
decarboxylation steps on one substrate molecule. Reaction intermediates are 
rather released from the enzyme then shuttled to the partner active site for the 
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next step in coproporphyrinogen III formation. The dimer formation seems to be 
important for UROD folding and conformation stability (Phillips et al., 2009). 
 
 
Figure 1.10: Proposed reaction mechanism for uroporphyrinogen III decarboxylase. 
The acetate side chains of uroporphyrinogen III are converted into methyl groups by 
uroporphyrinogen III decarboxylase. To date it is proposed that in the active centre Arg37 serves 
as H+ donor to the Asp86-stabilised substrate. R = tetrapyrrole; P = propionate side chain (modified 
after Lewis and Wolfenden, 2008; Silva and Ramos, 2005) 
 
 
1.6 Coproporphyrinogen III Oxidase  
 
Coproporphyrinogen III oxidase is the sixth enzyme in the tetrapyrrole 
biosynthesis. It catalyses an oxidative decarboxylation which results in a 
conversion of the propionate side chains of ring A and B of coproporphyrinogen III 
to the corresponding vinyl groups to yield protoporphyrinogen IX. Two molecules 
CO2 are released during the reaction and a final electron acceptor is required to 
take up two electrons from each side chain (Figure 1.11).  
In nature two different types of enzymes are found: the oxygen-dependent form 
encoded by hemF and the oxygen-independent enzyme encoded by hemN. Both 
share no obvious amino acid sequence identity which indicates an independent 
evolution.  
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Figure 1.11: The oxidative decarboxylation of coproporphyrinogen III to 
protoporphyrinogen IX. 
 
Coproporphyrinogen III is oxidatively decarboxylated to protoporphyrinogen IX whereby the 
propionate side chains of ring A and B are converted into the corresponding vinyl groups. Two 
molecules CO2 are released during the reaction and a final electron acceptor is required to take up 
four electrons from the modified side chains. M = methyl group (modified after Layer et al., 2006) 
 
 
Oxygen-dependent coproporphyrinogen III oxidase (HemF) is principally found in 
eukaryotes, only some bacteria possess the hemF gene (Panek and O'Brian, 
2002). The enzyme has been investigated from several organisms like yeast 
(Zagorec et al., 1988), mammals (Kohno et al., 1993; Martasek et al., 1994), 
plants (Madsen et al., 1993), S. typhimurium (Xu and Elliott, 1993) as well as 
E. coli (Troup et al., 1994). The amino acid sequences from different organisms 
are highly conserved. HemF is a homodimer of two identical subunits carrying 
different metal ions e.g. manganese in E. coli, copper in mouse and iron in yeast. 
In contrast, the human structure was shown to be metal free. Molecular oxygen is 
required as terminal electron acceptor which results in a release of carbon dioxide 
(Breckau et al., 2003; Kohno et al., 1996; Labbe et al., 1985; Medlock and Dailey, 
1996; Phillips et al., 2004). Early studies revealed that the propionate on ring A is 
decarboxylated prior to that on ring B (Jackson et al., 1980a; Jackson et al., 
1980b). However, the mechanism is poorly understood and several proposals had 
been made (Lash, 2005; Lee et al., 2005; Silva and Ramos, 2008). 
Most bacteria utilise the oxygen-independent coproporphyrinogen III oxidase 
(HemN). Activity under anaerobic conditions was first described in cell free extract 
from R. sphaeroides with a complex mixture of cofactors like NADP+, NADH, 
MgSO4, L-methionine, ATP and S-adenosyl-L-methionine (SAM; Tait, 1969, 
- 16 - 
Introduction 
1972). Since then, hemN genes from several bacteria have been cloned and 
sequenced e.g. S. typhimurium, E. coli, R. sphaeroides, Alcaligenes eutrophus 
and B. subtilis. Furthermore, a HemN like enzyme was described in B. subtilis. 
The so called HemZ has an amino acid homology to HemN and has been 
proposed to be involved into an oxygen-independent reaction (Coomber et al., 
1992; Homuth et al., 1999; Lieb et al., 1998; Troup et al., 1995; Xu and Elliott, 
1994). HemN belongs to the family of radical SAM enzymes (Layer et al., 2002; 
Sofia et al., 2001). The crystal structure of E. coli HemN revealed a monomer 
which contains a catalytical essential [4Fe-4S] cluster coordinated by a conserved 
amino acid motif which consists of three cysteine residues (Layer et al., 2003). 
The enzyme requires additionally SAM for catalysis (Figure 1.12).  
 
 
Figure 1.12: The proposed oxidative decarboxylation of coproporphyrinogen III to 
protoporphyrinogen IX by HemN. 
 
(a) The S-adenosyl-L-methionine (SAM) cleavage reaction catalysed by radical SAM enzymes. The 
reduced [4Fe-4S] cluster is used for the homolytic cleavage of SAM to yield methionine and a 
catalytically active 5’-deoxyadenosyl radical (Ado). (b) The proposed reaction mechanism for the 
HemN reaction. The adenosyl radical (Ado) is proposed to abstract a hydrogen atom from the  
β-carbon of the coproporphyrinogen III propionate side chains resulting in the formation of a 
substrate radical. Release of CO2 and uptake of the remaining electron by an external electron 
acceptor leads to protoporphyrinogen IX formation. M = methyl groups; R = tetrapyrrole (modified 
after Layer et al., 2006). 
 
 
HemN uses the iron-sulphur cluster to transfer an electron from an electron donor 
such as ferredoxin to SAM. Thereby, methionine and a 5-desoxyadenosyl radical 
is produced (Layer et al., 2002; Layer et al., 2005). The 5-desoxyadenosyl radical 
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then abstracts a hydrogen atom from the β-carbon of substrate propionate side 
chain resulting in the formation of a coproporphyrinogenyl radical and  
5’-deoxyadenosine (Layer et al., 2006). Finally, decarboxylation and transfer of a 
remaining single electron to a yet unidentified final electron acceptor leads to 
formation of the corresponding vinyl group of reaction product (Figure 1.12). This 
reaction has to pass through twice. Recently, it could be shown that HemN 
decarboxylates the propionate of ring A prior to ring B (Rand et al., 2010). 
 
 
1.7 Disorders in Tetrapyrrole Biosynthesis Lead to Diseases 
 
Tetrapyrroles are essential cofactors in most archaea, bacteria and eukaryotes. 
Perturbation in the biosynthesis pathway causes diverse dysfunctions and 
damages to the cells. The tetrapyrrole biosynthesis is subjected to strict regulation 
mechanism. In plants, perturbation of tetrapyrrole anabolism induces cell damage 
based on accumulation of photoreactive chlorophyll intermediates, which can 
result in a reduced photosynthesis capacity (Lermontova et al., 1997; Mock and 
Grimm, 1997; Mock et al., 1999). In humans, haem is synthesised in every cell for 
respiratory and oxidation-reduction reactions. A variety of gene mutations 
concerning the synthesis enzymes cause rare heterogeneous metabolic disorders 
commonly known as porphyrias (Roehl et al., 1998). Porphyrias manifest with 
broad range of cutaneous symptoms and/or acute neurological attacks because of 
the synthesis intermediates toxicity. Depending on their solubility, the 
overproduced porphyrins and porphyrin precursors accumulate and are excreted 
in urine and stool. Cutaneous photosensitivity is a result of the production of free 
radicals when porphyrins, like uro-, copro- and protoporphyrinogen, deposited in 
the skin are exposed to ultraviolet light at a wavelength of approximately 400 nm 
(Sandberg and Romslo, 1981; Wood et al., 1995). Neurovisceral symptoms are 
believed to result from neurotoxicity of 5-aminolaevulinic acid and porphobilinogen. 
Usually, haem production in the cells is controlled via negative feedback regulation 
of the 5-aminolaevulinic acid synthase activity by haem (Fraser et al., 2002; 
Thunell, 2006) and by iron availability in the erythropoietic cells (Smith and Cox, 
1997). Except for porphyria cutanea tarda (PCT), all types of porphyria show an 
autosomal inheritance pattern. PCT is the most common type which is caused by 
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uroporphyrinogen III decarboxylase (HemE) deficiency. Twenty five percent of the 
PCT cases are classified as familial type which results from an autosomal-
dominant inheritance with a 50 % enzyme activity deficit in all tissues. The 
remaining 75 % are described as acquired sporadic type whereby enzymatic 
deficiency is exclusively expressed in liver. Trigger factors like alcohol abuse, 
haemodialysis, iron overload, oestrogen and viral infections have been described 
to initiate this PCT type (Kauppinen, 2005; van Serooskerken et al., 2010). 
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1.8 Aim of This Study 
 
Several open questions related to various steps of haem biosynthesis in humans 
and bacteria should be investigated in the cause of this thesis. 
 
Recently newly density-functional studies of the mechanism for the cofactor-free 
decarboxylation performed by human uroporphyrinogen III decarboxylase revealed 
new potential arginine residues of the enzyme active site which may serve as 
proton donor for catalysis. In order to investigate the influence of these highly 
conserved arginine residues (R37 and R41) for decarboxylation, mutant variants of 
UROD were generated and biochemically characterised. The determination of 
kinetic parameters was aimed to resolve their contribution for catalysis. 
 
The second objective of this work was to study interactions and the existence of 
protein complexes of different enzymes involved in early steps of tetrapyrrole 
biosynthesis in T. elongatus. For this purpose, the T. elongatus genes coding for 
HemB, HemD, HemE and HemN should be cloned into expression vectors and 
their encoded proteins recombinantly produced. Subsequently, antibodies were 
aimed to be generated directed against the purified recombinant proteins. Finally, 
these antibodies should provide the basis for coimmunoprecipitation and electron 
microscopic experiments in order to prove the existence of interaction and 
complex formation in vitro as well as in vivo. 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
2 MATERIALS AND METHODS  
 
2.1 Instruments and Chemicals 
2.1.1 Instruments 
 
Agarose gel electrophoresis Agagel  Biometra 
Agarose gel documentation GelDoc   Bio-Rad 
Anaerobic chamber MACS-MG-1000 anaerobic workstation DW Scientific 
Autoclave LVSA 50/70  Zirbus 
Blotting equipment Semidry-Blot Trans-Blot®SD BioRad 
Centrifuges 5804 Eppendorf 
 Minispin Eppendorf 
 Biofuge primoR Heraeus 
 Avantis®J-26XP Beckmann Coulter 
 RC 5B Plus Sorvall 
 Qik Spin QS 7000 Edwards Instruments 
 Speed Vac SPD 110B Savant 
DNA sequencing Genetic Analyzer ABI PrismTM 310 Applied Biosystems 
Electrophoresis power supply PowerPac 300 BioRad 
FPLC Äkta PurifierTM  900 series Amersham Biosciences 
French press French® Pressure Cell Press Amersham Biosciences 
Homogenizer FastPrep 24 Instruments MP Biomedicals 
HPLC Jasco 1500 series Jasco 
pH-determination pH Meter C 6840 B Schott 
Pipettes Reference Eppendorf 
Scales BL 1500 Sartorius 
 BL 61S Sartorius 
 SBA 52 Scaltec 
SDS-PAGE-system Mini Protean II Bio-Rad 
Thermocycler Tpersonal Biometra 
 Tgradient Biometra 
Thermomixer Thermomixer compact Eppendorf 
Ultrasonic bath  Merck eurolab 
Ultrasound device Sonoplus HD 2070 Bandelin 
UV/visible spectrophotometer Ultrospec 2000 Amersham Biosciences 
Vortex Vortex-Genie 2 Scientific Industries 
Water bath shaker Aquatron Infors AG 
Water purification  Milli-Q System Millipore 
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2.1.2 Chemicals and Kits 
 
Antibodies anti-His6 (murine) GE Healthcare 
 anti-mouse (Fc-specific; goat) 
       alkaline phosphatase conjugated 
Sigma-Aldrich 
 anti-GST (rabbit) Sigma-Aldrich 
 anti-rabbit (Fc-specific) ImmunoPure®Goat 
       alkaline phosphatase conjugated 
Pierce 
Blotting material Gel blotting Paper Roth 
 Roti-PVDF-membrane Roth 
Chemicals 5-aminolaevulinic acid Merck 
 Coproporphyrin III Porphyrin Products 
 Uroporphyrin III Porphyrin Products 
 Bicinchoninic Acid Kit for Protein     
       Determination 
Sigma – Aldrich 
 Complete Mini, protease inhibitor cocktail  
       tablets 
Roche 
Enzymes PhusionTM DNA Polymerase Finnzymes 
 Benzonase® Nuclease Novagen 
 T4 DNA Ligase New England Biolabs 
 Restriction enymes New England Biolabs 
Kits BigDye Terminater v1.1 Cycle  
       Sequencing Kit 
Applied Biosystems 
 QIAquick Gel Extraction Kit Qiagen 
 QIAquick PCR Purification Kit Qiagen 
 QuikChange®II Site-Directed  
       Mutagenesis Kit 
Stratagene 
Molecular weight standards GeneRulerTM DNA Ladder Mix MBI Fermentas 
 MassRulerTM DNA Ladder Mix MBI Fermentas 
 PageRulerTM Prestained Protein Ladder MBI Fermentas 
 Unstained Protein Molecular Weight Marker MBI Fermentas 
PCR materials Oligonucleotides Metabion, Biomers 
 Nucleotides (dNTPs) Fermentas 
Other materials Dialysis VISKING, type 27/32            
       exclusion 14,000 
Roth 
 Glutathione sepharose 4 FF GE Healthcare 
 InstantBlueTM Expedeon 
 Ni2+-NTA column, HiTrap™Chelating HP Amersham Biosciences 
 Steril filter (0.2 µm) Millipore 
 Vivaspin concentrator Vivascience 
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Chemicals and reagents not specifically listed were purchased from the following 
manufacturers: Amersham Biosciences, Fluka, Gebru, Merck, Roth, Fisher 
Scentific and Sigma-Aldrich. 
 
 
2.2 Strains and Plasmids 
 
All strains and plasmids used for this work are listed in Table 1 and Table 2. 
 
Table 1: Employed bacterial strains. 
Strains Description Reference 
   
Escherichia coli  
DH10β 
F-mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80lacZ∆M15 ∆lacX74 recA1 endA1 
ara∆139 ∆(ara,leu)7697 galU galK λ-
rpsL (strR) nupG 
Invitrogen 
   
Escherichia coli  
BL21(DE3)RIL 
F- ompT hsdS(rB-mB-) dcm+ tetR 
galλ(DE3) endA Hte[argU ileY leuW 
cmR] 
Stratagene 
   
Escherichia coli 
BL21(DE3)pLysS 
F- ompT hsdS(rB-mB-) dcm+ galλ(DE3) 
[pLysS cmR] 
Stratagene 
   
Escherichia coli  
Rossetta (DE3)pLysS 
F- ompT hsdSB(rB-mB-) dcm+ gal 
(DE3) [pLysSRARE R cm ] 
Novagen 
   
Escherichia coli  
Rosetta gami 2 (DE3) 
∆(ara-leu)7697 ∆lacX74 ∆phoA Pvull 
phoR araD139 ahpC galE galK rpsL 
(DE3) F[lac+ laclq pro] gor522::Tn10 
trxB pRARE2 (cmR, strR, tetR) 
Novagen 
   
Thermosynechococcus 
elongatus BP-1 
wild type Yamaoka et al., 1978 
   
Bacillus megaterium 
MS941 
∆nprM mutant of wild type strain 
B. megaterium DSM319 
Wittchen and Meinhardt, 
1995 
 
 
Table 2: Plasmids used in this study. 
Plasmid Description Reference 
   
pET32a Expression vector carrying C-terminal 
His-Tag® and S-tag sequence, T7 
promotor, ampR 
Novagen 
   
pGEX-6P-1 Expression vector carrying N-terminal 
sequence for GST from 
Schistosoma japonicum and 
recognition sequence from 
PreScissionTM Protease, lac promoter, 
ampR 
Amersham Biosciences 
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Table 2 (continued): Plasmids used in this study. 
Plasmid Description Reference 
   
pHT#77 pAED4 derivate encoding human 
UROD, ampR 
Phillips et al., 1997 
   
pHT#77-R37A pHT#77 with exchange of triplet CGC 
(nucleotides 109-111) to GCC, protein 
carries alanine instead of arginine  
this work 
   
pHT#77-R37K pHT#77 with exchange of triplet CGC 
(nucleotides 109-111) to AAA, protein 
carries lysine instead of arginine  
this work 
   
pHT#77-R41A pHT#77 with exchange of triplet CGA 
(nucleotides 121-123) to GCC, protein 
carries alanine instead of arginine  
this work 
   
pHT#77-R41K pHT#77 with exchange of triplet CGA 
(nucleotides 121-123) to AAA, protein 
carries lysine instead of arginine  
this work 
   
pGA15hemD_T._elongatus pGA15 derivate encoding 
T. elongatus UROS with optimised 
codon usage for intracellular 
production of protein in 
B. megaterium, kanR 
GeneArt AG 
   
pN-HIS-TEV1622 pSTOP1622 derivate; vector for 
intracellular production of N-terminal 
His6-tagged proteins in 
B. megaterium; PxylA-His6-Tag-TEV-
MCS-Stop, tetR, B. megaterium; 
ampR, E. coli 
Biedendieck et al., 2007 
   
pKMBm4 pSSBm44 derivate; vector for 
intracellular production of proteins in 
B. megaterium; tetR, B. megaterium; 
ampR, E. coli 
Stammen et al., 2010 
   
pN-HIS-TEV1622-hemD pN-HIS-TEV1622 derivate encoding 
UROS from T. elongatus with 
optimised codon usage for 
intracellular production of protein in 
B. megaterium 
this work 
   
pKMBm4-hemD pKMBm4 derivate encoding UROS 
from T. elongatus with optimised 
codon usage and additional N-
terminal His6-tagged for intracellular 
production of protein in 
B. megaterium 
this work 
   
pET32a-TEhemB pET32a derivate encoding PBGS 
from T. elongatus 
this work 
   
pGEX6P-1hemD pGEX-6p-1 derivate encoding UROS 
from T. elongatus 
Frese, 2008 
   
   
- 24 - 
Materials and Methods 
Table 2 (continued): Plasmids used in this study. 
Plasmid Description Reference 
   
pET32a-TEhemE pET32a derivate encoding UROD 
from T. elongatus 
this work 
   
pGEX-TEhemN pGEX-6p-1 derivate encoding CPO 
from T. elongatus 
this work 
 
 
2.3 Growth Media and Media Additives 
2.3.1 Growth Media 
 
As a standard medium for growth of all Escherichia coli and Bacillus megaterium 
strains Luria Bertani (LB) medium was used (Sambrook and Russell, 2001), 
unless indicated otherwise. All strains were grown at 37 °C and 200 rpm.  
All media were autoclaved for 20 min at 121 °C. For solid media 15 g/L agar-agar 
was added before sterilisation. 
 
LB-Medium tryptone 10 g/L
 NaCl 5 g/L
 yeast extract 5 g/L
        in H2Odest.  
 
 
2.3.2 Media Additives 
 
Antibiotics and other additives were prepared as concentrated stock solutions, 
sterilised by filtration and added to the sterile medium. Stock solutions were stored 
at -20 °C. Solutes and concentrations are summarised in Table 3. 
 
Table 3: Media Additives 
Substance Solute Concentration of 
stock solution 
Final concentration 
    
Ampicillin H2Odest 100 mg/mL 100 µg/mL
    
Chloramphenicol 70 % ethanol (v/v) 34 mg/mL 34 µg/mL
   
Tetracycline 70 % ethanol (v/v) 5 mg/mL 5-10 µg/mL
    
Isopropyl-1-thio-ß-D- 
galactopyranoside 
(IPTG) 
H2Odest                        1 M            100-400 µM 
    
Xylose H2Odest         50 % (w/v) 0.5 % (w/v)
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2.4 Microbiological Techniques  
2.4.1 Sterilisation 
 
All media, solutions and glass equipments were vapour sterilised at 121 °C and 
1 bar positive pressure for 20 min. Temperature sensitive solutions were sterilised 
by filtration (pore width 0.2 µm). 
 
 
2.4.2 Cultivation of Bacteria  
 
Precultures (volume 5 up to 200 mL) of E. coli strains containing appropriate 
plasmids were grown in LB (with required additives) overnight at 37 °C and 
200 rpm in baffled flasks. After inoculation with preculture (1:100), 500 mL cultures 
were grown at 37 °C to an OD578 of 0.6. Protein production was induced with 
indicated amounts of Isopropyl-1-thio-ß-D-galactopyranoside (IPTG). After 
induction, cultures were incubated at 25 °C for 6 h or overnight.  
100 mL precultures of B. megaterium MS941 were grown in LB with tetracycline 
(10 µg/mL) at 100 rpm and 37 °C overnight. 250 mL cultures for protein 
production, inoculated with preculture (1:100), were grown at 37 °C until induction 
of protein production with 0.5 % (w/v) xylose.  
Agar plates were either utilized for plating 50-100 µL of bacterial cell suspension 
with a Drigalski spatula, or for streaking cells with an inoculating loop with liquid 
culture or with a single colony. Plates were incubated at 37 °C overnight. 
 
 
2.4.3 Determination of Cell Density 
 
The cell density of liquid cultures was determined by measuring the optical density 
(ODλ) at a wavelength of 578 nm. An OD578 of 1 corresponds to approximately 
1 x 109 E. coli cells per millilitre.  
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2.4.4 Storage of Bacterial Strains  
 
E. coli strains were stored on agar plates at 4 °C for up to four weeks and 
B. megaterium for up to 10 days, respectively. To prevent dehydration the plates 
were sealed with Parafilm®. For long-term storage glycerol stocks were prepared. 
Therefore, 0.4 mL overnight cultures were mixed with 1.2 mL sterile glycerol (80 % 
(v/v)), cooled on ice for 30 min, immediately frozen and stored at -80 °C. 
 
 
2.5 Molecular Biology Techniques  
2.5.1 Preparation of DNA 
 
2.5.1.1 Genomic DNA  
 
Thermosynechococcus elongatus BP-1 cells were provided by Frederike Frese 
(Frese, 2008). After harvesting by centrifugation (5 min at 7,000 x g), cells were 
washed once in TE buffer and suspended in 4 mL lysis buffer A supplemented 
with 0.2 mg/mL RNase A and 50 µg lysozyme. The samples were incubated at 
37 °C for 45 min. After addition of 500 µL N-laurosylsarcosinine (20 % (w/v)) and 
further incubation for 5 min at 37 °C the suspension was mixed with one volume of 
phenol and incubated under constant motion for 30 min at room temperature (RT). 
After subsequent centrifugation (20 min at 7,000 x g), the upper aqueous phase 
was transferred into a fresh tube and submitted to 4 mL 
phenol/chloroform/isoamylalcohol (24:24:1). Following 15 min of incubation, 
samples were centrifuged again and the phenol-chloroform extraction was 
repeated. The upper aqueous phase of this step was transferred into a fresh tube 
and DNA precipitation was initiated by addition of 10 mL pure ice cold ethanol and 
500 µL of a 3 M sodium acetate solution (pH 4.8). The sample was centrifuged for 
30 min (7,000 x g and 4 °C) and the DNA was washed twice with 500 µL 
70 % (v/v) ethanol. After evaporation of residual ethanol, the DNA was solubilised 
in 200 μL TE buffer and stored at 4 °C.  
 
Lysis buffer A NaCl 100 mM
 EDTA 50 mM
        in H2Odest; pH 8.0  
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TE buffer Tris-HCl 10 mM
 EDTA 1 mM
        in H2Odest; pH 8.0  
 
 
2.5.1.2 Plasmid DNA (Mini Prep) 
 
Four mL of an E. coli DH10β overnight culture were harvested by centrifugation 
(5 min at 14,000 x g). The sedimented cells were suspended in 300 µL of 
buffer P1. For cell lyses 300 µL of buffer P2 were added, carefully mixed by 
inverting the tube and incubated for 5 min at room temperature (RT). After addition 
of 300 µL of buffer P3 the sample was mixed carefully again and incubated on ice 
for 5 min. Cell debris and degraded proteins were sedimented by centrifugation 
(15 min at 14,000 x g). 600 µL of supernatant were transferred to 600 µL 
isopropanol into a fresh tube, incubated for 10 min at RT and centrifuged (30 min 
at 14,000 x g). The sedimented plasmid DNA was washed twice with 70 % (v/v) 
ethanol. After all traces of ethanol had evaporated, the DNA was solubilised in 50-
100 µL H2Odest. 
 
Buffer P1  Tris-HCl 50 mM 
 EDTA 10 mM 
 RNase A 100 mg/L 
        in H2Odest; pH 8.0  
   
Buffer P2 NaOH 200 mM 
 sodium dodecyl sulfate (SDS)        1 % (w/v)
        in H2Odest  
   
Buffer P3 potassium acetate         3 M 
        in H2Odest; pH 5.5  
        adjusted with acetic acid  
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2.5.2 Determination of DNA Concentration 
 
The concentration of a DNA solution was determined by measuring the 
absorbance at 260 nm and additionally at 280 nm to account for protein impurities. 
For a pure DNA solution an OD260 of one corresponds to a dsDNA concentration 
of 50 µg/mL (Sambrook and Russell, 2001). The purity of the DNA solution can be 
deduced from the ratio of OD260 to OD280. With an OD260/OD280 ratio of 1.8-2.0 the 
DNA was considered as pure.  
 
 
2.5.3 Agarose Gel Electrophoresis 
 
For the analytical separation of DNA fragments, agarose gels consisting of 
1 % (w/v) agarose in TAE buffer were prepared. Depending on the gel size, a 
voltage of 90-110 V was applied. DNA fragments migrate towards the anode with 
a velocity that is proportional to the negative logarithm of their size. Prior to 
loading, DNA samples were mixed with loading dye to facilitate loading and to 
indicate the progress of the samples in the gel. GeneRulerTM DNA Ladder Mix and 
MassRulerTM DNA Ladder Mix were used as size standard according to the 
manufacturer’s manual (Fermentas). After electrophoresis, gels were incubated in 
an ethidium bromide solution for 15-30 min and DNA was detected via its 
fluorescence under UV light (λ = 312 nm).  
 
TAE buffer Tris-acetate          40     mM 
 EDTA            1     mM 
        in H2Odest; pH 8.0  
   
DNA loading dye (5x) bromphenol blue     0.35 mM 
 xylene cyanol FF     0.45 mM 
 orange G     0.25 mM 
 glycerol          20      % (v/v) 
        in H2Odest  
   
Ethidium bromide  ethidium bromide            0.1   % (v/v) 
        in H2Odest  
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2.5.4 Cloning of DNA 
 
2.5.4.1 Amplification of DNA by Polymerase Chain Reaction (PCR) 
 
For amplification of haem genes involved in the haem biosynthesis of T. elongatus 
by PCR, oligonucleotide primers were designed with additional recognition 
sequences for restriction endonucleases. Oligonucleotides primers are listed in 
Table 4. Recognition sequences of restriction endonucleases are underlined. 
 
Table 4: Oligonucleotide primers used for amplification of DNA fragments. 
 “for” refers to forward and “rev” to reverse primer. Restriction sites are underlined 
Primer designation Sequence of oligonucleotide primer  
(5’→ 3’) 
Additional 
information 
   
hemBEcoR1for CGCCCGGAATTCATGGAGCTAACC EcoRI restriction site 
hemBNot1rev TTGCGGCCGCATAGTTCAATCCC NotI restriction site 
TE_hemE_EcoR1for CCCCGGAATTCATGACCACCC EcoRI restriction site 
TE_hemE_Not1rev TTGCGGCCGCATTAGGCGAGG NotI restriction site 
TE_hemN_EcoR1for CCCCGGAATTCATGAGTGTGGTTC EcoRI restriction site 
TE_hemN_Not1rev CTATTGCGGCCGCACTAAATGGCCTTAG NotI restriction site 
 
 
PhusionTM DNA polymerase (Finnzymes) was used for all reactions. PCR was 
performed in a total volume of 50 µL. After an initial DNA denaturation step, a 
cycle consisting of the three steps denaturation, primer annealing and primer 
elongation was completed 30 times. The reaction terminated by a final elongation 
step. The denaturation temperature of 98 °C and the elongation temperature of 
72 °C remained unchanged. The annealing temperature depended on 
oligonucleotide length and G+C content and was furthermore influenced by the 
insertion of mismatches. The melting temperature (Tm) was calculated as followed: 
 
Tm [°C] = 69.3 + 0.41(% G+C) – 650/n 
 
% G+C represented the G+C content of the primer in % and n represented the number of 
nucleotides. 
 
The duration of the elongation step was chosen according to the length of the DNA 
fragment to be amplified according to the manufacturer’s manual. 
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Standard thermocycler program for PhusionTM DNA polymerase: 
 
denaturation 98 °C   5 min  
denaturation 98 °C  30 sec  
annealing 60-70 °C  30 sec 30x 
elongation 72 °C      30 sec/kb  
elongation 72 °C  10 min  
 
 
2.5.4.2 Restriction of DNA 
 
Restriction of DNA (vector and PCR products) was carried out using restriction 
endonucleases purchased from New England Biolabs (Frankfurt am Main, 
Germany). Reaction buffers, concentrations of enzymes and DNA as well as 
incubation temperatures were chosen according to the manufacturer’s manual. 
The digestion was allowed to proceed for 5-6 h and was, if possible, followed by 
heat inactivation of the restriction endonucleases (20 min at 65 °C or 80 °C, 
depending on the enzyme). 
 
 
2.5.4.3 Purification of DNA  
 
For removal of polymerase, buffer and unbound nucleotides after amplification of 
DNA by PCR, the resulting PCR products were purified using the QIAquick® PCR 
Purification Kit (Qiagen; Hilden, Germany). Restriction endonucleases and buffer 
were removed from digested DNA (vector and PCR products) by agarose gel 
electrophoresis. The DNA fragment was excised from the gel and purified using 
the QIAquick® Gel Extraction Kit (Qiagen; Hilden, Germany). All kits were used 
according to the manufacturer’s manual. 
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2.5.4.4 Ligation of DNA 
 
Ligation of DNA was carried out using T4 DNA ligase (New England Biolabs; 
Frankfurt am Main, Germany) according to the manufacturer’s manual. An amount 
of 25-50 ng vector DNA was mixed with insert DNA (insert to vector ratio with 
regard to molar concentration ~ 5:1) in a final volume of 10 µL. Moreover, control 
reactions in the absence of ligase or insert were carried out. The reaction was 
incubated for 2 h at RT or at 17 °C overnight. 
 
 
2.5.5 Site-Directed Mutagenesis of DNA 
 
Single amino acids in a protein of interest can be exchanged by site-directed 
mutagenesis into the DNA sequence of the corresponding gene. The 
QuikChange® II Site-Directed Mutagenesis Kit (Stratagene; Böblingen, Germany) 
was employed in this work for mutational analysis of human uroporphyrinogen III 
decarboxylase (UROD). The method utilises a dsDNA plasmid carrying the gene 
of interest and two synthetic oligonucleotide primers which contain the desired 
mutation (see Table 5) and are complementary to opposite strands of the vector. 
During PCR with PfuUltra HF DNA polymerase a mutated plasmid is generated 
(figure 2.1). The PCR product was treated with DpnI, an endonuclease specifically 
digesting partially methylated DNA, here, the parental template DNA. This allows 
isolation of the newly in vitro synthesized unmethylated DNA of the mutated 
plasmid with which a suitable E. coli strain was subsequently transformed. PCR 
reactions with the QuikChange® II Site-Directed Mutagenesis Kit were carried out 
according to the manufacturer’s manual. However, the volume of the PCR reaction 
was reduced to 25 µL. Compentent E. coli XL 1 Blue cells were transformed with 
the mutated plasmids.   
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Figure 2.1: Outline of the QuikChange® Procedure. 
Overview of the QuikChange® Site-Directed mutagenesis method (modified from Stratagene 
Instruction Manual, 2007) — parental DNA, — mutated DNA, X position of the desired mutation, → 
mutagenic primer, X introduced mutation. A detailed description is given in the text.  
 
 
Table 5: Oligonucleotide primers used for site-directed mutagenesis of human  
  uroporphyrinogen III decarboxylase. 
  “for” refers to forward and “rev” the reverse primer. Changed nucleotides are underlined 
Primer designation Sequence of oligonucleotide primer  
(5’→ 3’) 
  
R37Afor GTTTGGTGCATGGCCCAGGCAGGCCG 
R37Arev CGGCCTGCCTGGGCCATGCACCAAAC 
R37Kfor GTTTGGTGCATGAAACAGGCAGGCCG 
R37Krev CGGCCTGCCTGTTTCATGCACCAAAC 
R41Afor CGCCAGGCAGGCGCCTACTTACCAGAG 
R41Afrev CTCTGGTAAGTAGGCGCCTGCCTGGCG 
R41Kfor CGCCAGGCAGGCAAATACTTACCAGAG 
R41Krev CTCTGGTAAGTATTTGCCTGCCTGGCG 
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2.5.6 Transformation of Bacteria 
 
2.5.6.1 Transformation of Escherichia coli Cells by the RbCl2 Method 
 
E. coli cells were grown in 500 mL LB with required additives under aeration. 
When the culture obtained an OD578 of 0.6 cells were harvested by centrifugation 
(10 min at 6,000 x g and 4 °C), subsequently gently suspended in 200 mL ice cold 
TFB1 and incubated on ice for 5 min. Once more the cells were harvested (5 min 
at 3,000 x g and 4 °C) and suspended in 2 volumes of ice cold TFB2 (referring to 
the volume of cell sediment), incubated on ice for 45 min and divided into 50 µL 
aliquots. These were either immediately used for transformation or stored at  
-80 °C. 
For transformation, 40 µL RbCl2-competent cells were combined with 1-2 µL DNA 
solution (50 µg/mL) and incubated for 30 min on ice. Afterwards the transformation 
mix was subjected to a heat shock for 45 sec at 42 °C and cooled on ice for 3 min. 
One mL of preheated LB medium was added and cells were incubated at 37 °C for 
45 min. Depending on the expected colony density, different volumes were 
streaked on agar plates containing the appropriate antibiotics. Plates were 
incubated overnight at 37 °C. 
 
TFB1 potassium acetate  30 mM 
 CaCl2  10 mM 
 MnCl2  50 mM 
 RbCl2           100 mM 
 glycerol       15 % (v/v) 
        in H2Odest; pH 5.8  
        adjusted with acetic acid   
   
TFB2 MOPS  10 mM 
 CaCl2  75 mM 
 RbCl2  10 mM 
 glycerol       15 % (v/v) 
        in H2Odest; pH 6.5  
        adjusted with potassium   
       hydroxide 
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2.5.6.2 Protoplast Transformation of Bacillus megaterium Cells  
 
The B. megaterium MS941 protoplasts were provided by Simon Stammen (Institut 
für Mikrobiologie, TU Braunschweig, Germany). For transformation of the 
protoplasts, 5 µg plasmid DNA were dried and dissolved in 10 µL SMMP for 
20 min at 37 °C. A 500 µL aliquot of protoplasts was gently mixed with the plasmid 
DNA and added to 1.5 mL PEG-P solution. After incubation for 2 min at RT, 5 mL 
SMMP were added and the reaction was gently mixed. The protoplasts were 
harvested by centrifugation (10 min at 1,300 x g and RT), subsequently the 
protoplast were carefully suspended in 500 µL SMMP and incubated at 30 °C for 
45 min without shaking, followed by 45 min of smooth shaking at 300 rpm 
(Thermomixer compact). The regenerated protoplasts were mixed with 2.5 mL of 
42 °C CR5-top agar and added on a preheated agar plate containing tetracycline 
(10 µg/mL). The plates were incubated at 30 °C for up to 24 h. Formed colonies 
were streaked out on new LB medium agar plates containing tetracycline 
(10 µg/mL). 
 
SMMP 2 x AB3 and 2 x SMM; mixed 1 : 1  
   
          2 x AB3 antibiotic medium No.3 (Difco)              35      g/L 
          2 x SMM malic acid              40      mM 
 MgCl2              40      mM 
 NaOH              80      mM 
 sucrose                1      M 
        in H2Odest; pH 6.5  
   
PEG-P solution PEG 6000              40     % (w/v) 
 in 1 x SMM  
   
C5R-top agar solution A         1.25 mL 
 solution B            713      µL 
 8 x CR5-salts            288      µL 
 L-proline (12 % (w/v))            125      µL 
 D-glucose (20 % (w/v))            125      µL 
   
          Solution A sucrose            602      mM 
 MOPS              58      mM 
 NaOH              30      mM 
        in H2Odest; pH 7.3  
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          Solution B agar agar                 4    % (w/v) 
 casamino acids                 0.2 % (w/v) 
 yeast extract               10    % (w/v) 
        in H2Odest  
   
          8 x CR5-salts K2SO4               11    mM 
 MgCl2             394    mM 
 KH2PO4                 3    mM 
 CaCl2             159    mM 
        in H2Odest  
 
 
2.5.7 DNA Sequencing 
 
The modification of DNA (cloning as well as site-directed mutagenesis) was 
confirmed by sequence determination of the respective DNA region based on the 
Sanger method (Sanger et al., 1977). DNA sequences were obtained with an 
Abi PrismTM 310 Genetic Analyzer (Applied Biosystems). The required preparatory 
PCR with fluorescence-labeled ddNTPs and purification of the PCR product were 
carried out as described by the manufacturer. 
 
 
2.6 Protein Biochemical Methods 
2.6.1 Recombinant Production and Purification of Thermosynechococcus  
         elongatus Haem Proteins 
 
2.6.1.1 Cell Growth for Protein Production 
 
For recombinant production of haem proteins in E. coli, 2 x 500 mL LB medium 
containing ampicilin (100 µg/mL) and chloramphemicol (34 µg/mL) were 
inoculated (ratio 1:100) with an overnight culture of E. coli Rosetta gami2 (DE3) 
carrying pET32a-TEhemB for porphobilinogen synthase (PBGS) or pET32a-
TEhemE for uroporphyrinogen III decarboxylase (UROD), respectively. E. coli 
Rosetta (DE3)pLysS carrying pGEX6P-1hemD was used for uroporphyrinogen III 
synthase (UROS) and pGEX-TEhemN for coproporphyrinogen III oxidase (CPO), 
respectively. Cultures were grown aerobically in 1 L Erlenmeyer flasks at 37 °C 
and 200 rpm to an OD578 of 0.6. The production of proteins was induced by 
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addition of IPTG to a final concentration of 400 µM. Incubation was continued 
overnight at 25 °C and 180 rpm. Cells were harvested by centrifugation for 15 min 
at 4,000 x g and 4 °C. The cell sediments were stored at -20 °C. 
For recombinant production of proteins in B. megaterium MS941, carrying pN-HIS-
TEV1622-hemD and pKMBm4-hemD, respectively, 100 mL precultures were 
inoculated by a single colony from a LB agar plate and grown in LB with 
tetracycline (10 µg/mL) at 100 rpm and 37 °C overnight. 250 mL cultures were 
inoculated at a ratio of 1:100 with the preculture. The cultures were incubated at 
37 °C and 250 rpm in a water bath shaker. After reaching an OD578 of 0.4, 
recombinant protein production was induced by adding 0.5 % (w/v) xylose. 
Incubation was continued for 8 h. For analysis of the intracellular protein fractions 
(see chap. 2.6.3.2), samples were taken at different time points after induction. 
Cells were harvested by centrifugation for 15 min at 4,000 x g and 4 °C. The cell 
sediments were stored at -20 °C. 
 
 
2.6.1.2 Cell Disruption 
 
The E. coli cell sediments were suspended in lysis buffer B and disrupted by a 
single passage through a French Press® homogenizer at 19,200 psi. Cell debris 
and insoluble protein fraction were removed by centrifugation for 90 min at 4 °C 
and 25,000 x g. The resulting supernatant was loaded onto a glutathione 
sepharose column for GST-tagged proteins or onto a Ni2+-NTA column for His-
tagged proteins. Proteins solutions were stored an ice. 
 
Lysis buffer B Tris-HCl                50   mM 
 NaCl              150   mM 
 MgCl2                10   mM 
 glycerol                10   % (v/v) 
 lysozyme                  5   mg/mL 
 Benzonase® Nuclease                  0.1 % (v/v) 
 protease inhibitor                  1   Tablet 
        in H2Odest; pH 7.5  
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To increase the protein solubility optional detergents such as CHAPS, Tesit octyl 
glycoside or TritonX-100 (concentration 0.2-2 % (v/v) or (w/v)) were added. 
 
 
2.6.1.3 Purification of Thermosynechococcus elongatus Porphobilinogen  
 Synthase (PBGS) by Affinity Chromatography 
 
Recombinant produced PBGS was purified by a Ni2+-NTA affinity chromatography 
using an ÄKTA PurifierTM with a 5 mL column, which was equilibrated with 
10 volumes of buffer A. All steps were carried out at RT, proteins were stored on 
ice. After loading the cell free extract on the column at a flow rate of 0.5 mL/min, 
the column was washed with 10 volumes of buffer A to remove unbound proteins. 
Bound proteins were eluted using a linear gradient of 0-200 mM imidazole in buffer 
A at a flow rate of 0.5 mL/min. Fractions containing PBGS were identified by SDS-
PAGE and stored at 4 °C. 
 
Buffer A Tris-HCl                    50 mM 
 NaCl                  150 mM 
 MgCl2                    10 mM 
 glycerol                    10 % (v/v) 
        in H2Odest; pH 7.5  
 
 
2.6.2 Recombinant Production and Purification Human Uroporphyrinogen III  
         Decarboxylase (UROD) 
 
2.6.2.1 Cell Growth for Protein Production 
 
For recombinant production of human UROD in E. coli, 20 x 500 mL LB medium 
containing ampicilin (100 µg/mL) and chloramphemicol (34 µg/mL) were 
inoculated (ratio 1:100) with an overnight culture of E. coli BL21(DE3)pLysS 
carrying pHT#77 for the wild type and pHT#77-R37K for the mutant variant R37K, 
respectively, or E. coli BL21(DE3)RIL transformed with pHT#77-R37A, pHT#77-
R41A or pHT#77-R41K for the mutant variants R37A, R41A and R41K, 
respectively. Cultures were grown aerobically in 1 L Erlenmeyer flasks at 37 °C 
and 200 rpm to an OD578 of 0.6 and production of proteins was induced by 
addition of IPTG to a final concentration of 400 µM. Incubation was continued for 
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6 h at 25 °C and 180 rpm. Cells were harvested by centrifugation for 15 min at 
4,000 x g and 4 °C. The cell sediments were stored at -20 °C. 
 
 
2.6.2.2 Cell Disruption 
 
The cell sediments were suspended in lysis buffer C and disrupted by a single 
passage through a French Press® homogeniser at 19,200 psi. Cell debris and 
insoluble protein fraction were removed by centrifugation for 90 min at 4 °C and 
25,000 x g. The resulting supernatants were loaded onto a Ni2+-NTA column. 
Proteins solutions were stored on ice. 
 
Lysis buffer C NaCl            300   mM 
 Sørensen’s buffer; pH 6.8              50   mM 
 glycerol              10   % (v/v) 
 Benzonase® Nuclease               0.1 % (v/v) 
 protease inhibitor               1    Tablet 
 
 
2.6.2.3 Purification by Affinity Chromatography 
 
Recombinant human UROD was purified by a Ni2+-NTA affinity chromatography 
using an ÄKTA PuifierTM with a 5 mL column, which was equilibrated with 
10 volumes of buffer B. All steps were carried out at RT, proteins were stored on 
ice. After loading the cell free extract at a flow rate of 0.5 mL/min, the column was 
washed with 10 volumes of buffer B to remove unbound proteins. Bound proteins 
were eluted using a linear gradient of 0-250 mM imidazole in buffer B at a flow rate 
of 0.5 mL/min. Fractions containing UROD were identified by SDS-PAGE and 
stored at 4 °C. 
 
Buffer B NaCl              300 mM 
 Sørensen’s buffer; pH 6.8                50 mM 
 glycerol                10 % (v/v) 
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2.6.3 Protein Characterisation 
 
2.6.3.1 Bicinchoninic Acid (BCA) Test 
 
Concentrations of protein solutions were determined using the Bicinchoninic Acid 
Kit for Protein Determination according to manufacturer’s instructions. Proteins 
reduce alkaline Cu(II) to Cu(I) in a concentration-dependent manner. Bicinchoninic 
acid is a highly specific chromogenic reagent for Cu(I) forming a purple complex 
with an absorbance maximum at 562 nm. The absorbance is directly proportional 
to protein concentration. Bovine serum albumin was used as a standard. 
 
 
2.6.3.2 Analysis of the Intracellular Protein Fractions from B. megaterium 
 
For analysis of the intracellular proteins fractions, samples containing 3 x 109 
B. megaterium cells were harvested (14,000 x g; 4 °C; 15 min) and the 
supernatant was completely removed afterwards. Subsequently, the cells were 
suspended in 30 µL lysis buffer D supplemented with 2 µL/mL benzonase and 
incubated at 37 °C at 1,000 rpm (Thermomixer compact) for 30 min. After 
centrifugation (14,000 x g; 4 °C; 30 min), 26 µL of the supernatant containing the 
soluble proteins were mixed with SDS loading dye and stored on ice. The 
sediment, containing the cell debris and the insoluble proteins, was suspended in 
30 µL of urea buffer and centrifuged for cell debris elimination (14,000 x g; 30 min 
and 4 °C). For analysis of the insoluble proteins, 26 µL supernatant were mixed 
with SDS loading dye. The samples were analysed by SDS-PAGE (see chapt. 
2.6.3.3) 
 
Lysis buffer D Na3PO4               100 mM 
 MgSO4                   2 mM 
 lysozyme 5 mg/mL 
        in H2Odest; pH 6.5  
   
Urea buffer Tris-HCl                 50 mM 
 urea                   8 M 
        in H2Odest; pH 7.5  
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5 x SDS loading dye Tris-HCl             100    mM 
 glycerol               40    % (v/v)
 β-mercaptoethanol               10    % (v/v)
 SDS 3.2 % (w/v)
 bromphenol blue 0.2 % (w/v)
        in H2Odest; pH 6.8  
 
 
2.6.3.3 Discontinuous Sulphate Polyacrylamide Gel Electrophoresis  
 
Proteins were analyzed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) as described by Laemmli (Laemmli, 1970) with 
modifications by Righetti (Righetti et al., 1990) for discontinuous SDS-PAGE. 
Protein samples were denatured by heating at 95 °C for 5 min in SDS loading dye. 
Samples were loaded onto the gel which was run at 45 mA. During 
electrophoresis, proteins were first focused in the stacking gel and subsequently 
separated according to their relative molecular mass in the running gel. The size 
standard employed was Protein Molecular Weight Marker. Gels were stained with 
staining solution and destained with destaining solution A or InstantBlueTM until 
protein bands were clearly visible.  
 
SDS gel   
 running gel [12 % (v/v)] stacking gel [6 % (v/v)] 
       Acrylamide stock solution   2      mL 500       µL 
       Buffer for running gel   1.25 mL - 
       Buffer for stacking gel - 625       µL 
       H2Odest   1.75 mL     1.375 mL 
       APS solution 50      µL   25       µL 
       Tetramethylethylen  
       diamine (TEMED) 
  5      µL     2.5     µL 
 
 
Acrylamide stock solution Rotiphorese® Gel 30 (37.5:1)  (Roth) 
   
Buffer for running gel Tris-HCl               1.5 M 
 SDS 0.4 % (w/v) 
        in H2Odest; pH 8.8  
   
Buffer for stacking gel Tris-HCl               0.5 M 
 SDS 0.4 % (w/v) 
        in H2Odest; pH 6.8  
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APS solution ammonium peroxodisulfate           10      % (w/v) 
        in H2Odest  
   
Tetramethylethylen diamine TEMED p.a. for    
       electrophoresis (Roth) 
          99      %(v/v) 
   
Electrophoresis buffer Tris-HCl           25      mM 
 glycine         190      mM 
 SDS             0.1   % (w/v) 
        in H2Odest; pH 8.4  
   
5 x SDS loading dye Tris-HCl         100      mM 
 glycerol           40      % (v/v) 
 β-mercaptoethanol           10      % (v/v) 
 SDS             3.2   % (w/v) 
 bromphenol blue             0.2   % (w/v) 
        in H2Odest; pH 6.8  
   
Staining solution A ethanol           30      % (v/v) 
 acetic acid           10      % (v/v) 
 Coomassie Brillant Blue G-250 0.25 % (w/v) 
        in H2Odest  
   
Destaining solution ethanol           30      % (v/v) 
 acetic acid           10      % (v/v) 
        in H2Odest  
 
 
2.6.3.4 Western Blot 
 
Proteins immobilised on a polyvinylidene fluoride (PVDF)-membrane (Roth) can 
be detected by antibodies. The primary antibody is directed against an epitope of 
the protein of interest and the secondary antibody is directed against the primary 
antibody. Furthermore the secondary antibody is coupled with an enzyme which 
catalyses a detectable colour developing reaction. For immunochemical detection, 
electrophoretically separated proteins were transferred in a semi-dry process onto 
a PVDF-membrane which binds the proteins by polar interactions. Therefore, the 
PVDF-membrane was activated in methanol for 15 min and, similarly to the SDS 
gel and the Whatman blotting paper, incubated for 15 min in Towbin buffer. 
Proteins were blotted onto the membrane for 15 min at 15 V per gel according to 
the manufacturer’s instructions. Non-specific binding sites of the membrane were 
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saturated overnight in blocking solution at 4 °C and slight shaking. Proteins 
immobilised on the PVDF-membrane were specifically detected by antibodies. For 
the detection of the His-tagged proteins, the membrane was incubated for 1 h (RT) 
and slightly shaking with the primary anti-His antibody, which was diluted 1:3,000 
in blocking solution. After washing with washing solution thrice for 10 min and 
subsequent incubation for 45 min with the secondary antibody (1:5,000 diluted in 
washing solution), which is directed against the primary antibody and coupled with 
alkaline phosphatase, the membrane was washed four times for 10 min with 
PBS/Tween. After 5 min of incubation with alkaline phosphate buffer the 
chemiluminescence reaction was performed with staining solution B until bands 
became visible. During exposure alkaline phosphatase, the enzyme bound to the 
antibody catalyses the reaction of 5-brom-4chloro-3indolylphosphate (BCIP) with 
nitroblue-tetrazolium (NBT).  
 
Towbin buffer Tris-HCl             25      mM 
 glycine           150      mM 
 methanol             10      % (v/v) 
        in H2Odest; pH 8.5  
   
10 x PBS NaCl               1.37 M 
 KCl             27      mM 
 Na2HPO4           100      mM 
 KH2PO4             20      mM 
        in H2Odest  
Blocking solution skim milk powder               5      % (w/v) 
 Tween 20               0.1   % (v/v) 
 10 x PBS             10      % (v/v) 
        in H2Odest  
   
Washing solution skim milk powder               0.5   % (w/v) 
 Tween 20               0.1   % (v/v) 
 10 x PBS             10      % (v/v) 
        in H2Odest  
   
PBS/Tween buffer Tween 20               0.1   % (v/v) 
 10 x PBS             10      % (v/v) 
        in H2Odest  
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Alkaline phosphate buffer Tris-HCl            100      mM 
 NaCl            100      mM 
 MgCl2                5      mM 
        in H2Odest; pH 9.5  
   
Staining solution B NBT solution                0.33 % (v/v) 
 BCIP solution                0.33 % (v/v) 
        in alkaline phosphate buffer  
   
NBT solution nitroblue-tetrazolium              10     % (w/v) 
 dimethylenformamide (DMF)              70     % (v/v) 
        in H2Odest  
   
BCIP solution 5-brom-4-chloro-3-indolylphosphate                5     % (w/v) 
        in DMF  
 
 
2.7 Enzyme Activity Assays 
2.7.1 Determination of Porphobilinogen Synthase Activity 
 
The activity of recombinantly produced and purified porphobilinogen synthase 
(PBGS) from T. elongatus was determined by using a modified Ehrlich’s test. The 
test based on the reaction between the product porphobilinogen and  
4-(dimethylamino)-benzaldehyde (DMBA). In a first reaction step porphobilinogen 
and DMBA form a pink reaction product which has an absorbance maximum at 
555 nm. This product subsequently reacts with a second porphobilinogen 
molecule to form a colourless dipyrrolphenylmethane (figure 2.2). Since the 
second reaction proceeds very slowly porphobilinogen concentrations can be 
quantified via the Beer-Lambert law.  
 
The Beer-Lambert law is as following: 
 
c = A/(d∗ε) 
 
c = concentration of porphobilinogen [M] 
A = absorption 
d = cell diameter [cm] 
ε = molar extinction coefficient of the coloured intermediate [M-1cm-1] 
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Figure 2.2 : Colorimetric Detection of Porphobilinogen. 
Porphobilinogen forms a coloured complex with DMBA which can be detected at OD555. This 
complex slowly reacts with a second porphobilinogen molecule to form colourless 
dipyrrolphenylmethane. The coloured intermediate has a molar extinction coefficient of ε(complex) 
= 60,200 M-1cm-1. 
 
 
The standard assay contained a final concentration of PBGS of 10 µg/mL. Purified 
PBGS from Pseudomonas aeruginosa, which served as positive control, was 
kindly provided from Ilka Heinemann (Heinemann, 2007). The substrate 
aminolaevulinic acid (ALA) was dissolved to a concentration of 40 mM in kinetic 
buffer A. Stock solutions of protein and buffer were mixed and incubated at 37, 45 
and 55 °C for 5 min. To start the reaction, preheated substrate was added to a 
final concentration of 10 mM and no ALA for the negative control, respectively. 
The reaction was stopped after 1 h by adding an equal amount of ice cold stop 
reagent. Following centrifugation (3 min and 4,000 x g at RT), the supernatant was 
treated with an equal amount of Ehrlich’s reagent. After 15 min at RT, the amount 
of formed porphobilinogen was determined by measuring the OD555 and 
calculated using the Beer-Lambert law as described above.  
 
Kinetic buffer A KCl             100    mM 
 MgCl2                 5    mM 
 bis-tris-probane             100    mM 
        in H2Odest; pH 8.4  
   
Stop reagent trichloroacetic acid               25    % (w/v) 
        in H2Odest  
   
Ehrlich’s reagent DMBA                 2    % (w/v) 
 acetic acid               27.3 % (v/v) 
 hydrochloric acid               72.7 % (v/v) 
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2.7.2 Determination of Uroporphyrinogen III Decarboxylase Activity 
 
2.7.2.1 Activity Assay 
 
The uroporphyrinogen III decarboxylase (UROD) activity assay was carried out 
under strict anaerobic conditions in an anaerobic chamber. All solutions were 
saturated with N2 prior to use. The standard assay mixture (see below) contained 
UROD (0.1 µM) and uroporphyrinogen III (0.025-35 µM) in potassium phosphate 
buffer in a total volume of 245 µL after a modified procedure as described earlier 
(Phillips and Kushner, 1999). After incubation at 37 °C in the dark for 30 min the 
reaction was stopped by addition of 10 µL concentrated hydrochloric acid and 
formed coproporphyrinogen III was oxidised for 15 min to coproporphyrin III by 
addition of 10 µL 30 % H2O2 (see figure 2.3). For protein removal the mixture was 
centrifuged (10 min and 14,000 x g at RT). The obtained supernatant was 
analysed by high performance liquid chromatography (HPLC). 
 
Standard assay mixture    
 potassium phosphate buffer; pH 6.8        50    mM 42.5 µL
 DTT          1    M 2.5 µL
 potassium phosphate buffer; pH 6.8          1    M     20   µL 
 UROD in DTT (0.1 M)/ 
       potassium phosphate buffer (0.1 M) 
         0.1 µM   175   µL 
 uroporphyrinogen III  
       in DTT (0.1 M)/ potassium phosphate  
       buffer (0.1 M) 
0.025-35 µM       5   µL 
 
 
 
 
Figure 2.3 : Conversion of Uroporphyrinogen III into Coproporphyrinogen III 
Uroporphyrinogen III decarboxylase catalyses the sequential decarboxylation of the four acetate 
residues of uroporphyrinogen III to yield the corresponding methyl groups of the product 
coproporphyrinogen III. 
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2.7.2.2 Preparation of Uroporphyrinogen III 
 
The substrate uroporphyrinogen III (uro’gen III) was obtained by reduction of 
uroporphyrin III (uro III) (Frontier Scientific) according to a modified procedure 
described by Grandchamp and Nordmann (Grandchamp and Nordmann, 1982): 
1.7 mg uro III were dissolved in 1.4 mL of KOH (50mM) and finally reduced with 
1 g of 3 % sodium amalgam under nitrogen atmosphere in the dark at RT. When 
the reaction mixture had decoloured, it was filtered through glass wool. 36 mg DTT 
were added and the mixture was filled up to a volume of 4.5 mL with Tris-HCl 
(50 mM, pH 8.0). The pH was adjusted to 8-8.5 with 20 % (v/v) phosphoric acid 
and 200 µL of 1 M Tris-HCl (pH 8.0) were finally added. The uro’gen III solution, 
which has a final concentration of 1.88 mM, was divided anaerobically and stored 
at -20 °C in the dark to avoid auto-oxidation. 
 
 
2.7.2.3 Uroporphyrinogen III Decarboxylase Activity Analysis by High  
            Performance Liquid Chromatography (HPLC)  
 
The uroporphyrinogen III decarboxylase activity was analysed by high 
performance liquid chromatography (HPLC).  For identification the reaction 
products were separated by a 1,500 series Jasco HPLC System. Therefore, 
100 µL of the reaction mixture supernatant was mixed with 100 µL acetone/HCl 
(ratio 9:10). An Equisil ODS (5 µm, 250 x 4.6 mm) C18 reversed phase column 
(Dr. Maisch GmbH, Ammerbuch) was run at 0.3 mL/min and 30 °C. Twenty µL of 
the sample were injected. Isocratic separation was performed using 40 % (v/v) 
ammonium acetate (pH 5.2) and 10 % (v/v) acetonitrile in methanol as mobile 
phase. Tetrapyrroles were detected by fluorescence measurement using an 
excitation wavelength of 409 nm and an emission wavelength of 618 nm. 
Uroporphyrin III and coproporphyrin III were used as standards. 
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3 RESULTS AND DISCUSSION 
 
This thesis investigated several different steps of haem biosynthesis in humans 
and bacteria. 
 
3.1 Characterisation of Human Uroporphyrinogen III Decarboxylase 
 
The successive decarboxylation of the acetate subunits of uroporphyrinogen III to 
form coproporphyrinogen III is catalysed by the cytosolic enzyme 
uroporphyrinogen III decarboxylase (UROD). Under physiological conditions, the 
decarboxylation follows a preferred, clockwise route, starting at ring D (Jackson et 
al., 1976; Luo and Lim, 1993). Dysfunction of the UROD leads to a disease which 
is commonly known as porphyria cutanea tarda. It is the most commun porphyria 
with a prevalence of 1 case in 25,000-50,000 population. 
For that reason URODs and especially the human UROD have been examinated 
for a long time. Another important reason for UROD being an object of interest is 
that the enzyme does not require a cofactors or prosthetic groups for enzymatic 
activity which mark UROD as a very unusual decarboxylase (de Verneuil et al., 
1980; de Verneuil et al., 1983; Straka and Kushner, 1983). Already early 
hypothesis about the reaction mechanisms had been made by Barnard and Akhtar 
(Barnard and Akhtar, 1979). They predicted that the enzyme itself served as 
proton donor for the reaction. Since then, a lot of different amino acid residues like 
cysteine, threonine, arginine and histidine had been exchanged by site directed 
mutagenesis and their impact on catalytic activity studied (Phillips et al., 2009; 
Wyckoff et al., 1996) as well natural occurring mutations had been a subject of 
interest (Phillips et al., 2001; Phillips et al., 2007).  
However, none of the studied residues led to complete molecular understanding of 
the catalytic properties of this unusual decarboxylase. The solved structure of 
substrate-bound human UROD shows that the negatively charged aspartate 86 is 
important for substrate stabilisation in the active site (Phillips et al., 2003; Whitby 
et al., 1998). Density-functional calculations of the mechanism led to the 
hypothesis that arginine 37, which lies close to the substrate, may be the proton 
donor for the reaction (Silva and Ramos, 2005). This is supported by earlier 
studies which showed that UROD is inactivated by the arginine-modyfing reagent 
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phenylglyoxal (Jones and Jordan, 1993). Lately, Silva concluded that a second 
arginine 41 residue served as second proton donor as well. Conserved amino 
acids residues were found among all species (Figure 3.1). For example, the 
suggested catalytic residues Asp37, Arg41 and Arg86 (numbered by human 
sequence) are highly conserved in the UROD family of proteins. Whereby, the 
importance of Arg86 had already been proven (Phillips et al., 2003; Whitby et al., 
1998). 
 
Figure 3.1: Alignment of UROD protein sequences. 
Ten amino acid sequences were aligned using ClustalW2 (EMBL-EBI). Residue numbering refers 
to the human sequence. An extract of the sequence is illustrated. Arg37, Arg41 and Asp86 
residues are green highlighted. These residues were proposed to be involved in the catalysis of 
UROD. GenBank database entries shown are Homo sapiens (U30787), T. elongatus (BAC08292), 
S. cerevisiae (Z49209), Rhodobacter capsulatus (U16796), N. tabacum (X82833), Helicobacter 
pylori (AE000511), Gallus gallus (XM422430), B. subtilis (M97208), A. thaliana (BAA97056) and  
E. coli (AAC76971). 
 
 
To investigate the influence of these highly conserved arginine residues as 
catalytic features, mutagenesis studies of human UROD arginines 37 and 41 were 
performed. Wild type human UROD and respective mutant variants were 
recombinantly produced in E. coli, purified and kinetically characterised. The 
enzymatic influence of these residues was determined by HPLC analysis. 
 
 
3.1.1 Production and Purification of Recombinant Human  
         Uroporphyrinogen III decarboxylase (UROD) 
 
According to the predicted mechanism of the uroporphyrinogen III decarboxylase 
(UROD) catalysis, a mutagenesis approach was untertaken to evaluate the 
chemical contribution of the residues Arg37 and Arg41 to enzymatic catalysis. 
Therefore, introduction of conservative and non-conservative amino acid 
exchanges for these residues was applied and single amino acid exchanges were 
conducted. Arg37 and Arg41 were individually replaced by lysine or alanine. The 
expression vector pHT#77 carrying the human hemE gene (Phillips et al., 1997), 
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which represented the human wild type UROD, served as template for site-
directed mutagenesis. The resulting constructs were verified for their correct gene 
sequence. 
Different E. coli strains were transformed with the wild type expression vector 
pHT#77 and the mutant variants, respectively. Recombinant protein production 
studies revealed best results in E. coli BL21(DE3)pLysS for the wild type and 
R37K mutant variant and E. coli strains BL21(DE3)RIL for the mutant variants 
R37A, R41A and R41K, respectively. Testing different time intervals of 
recombinant protein production yielded a maximum concentration of protein in the 
cell at six hours of production. The protein concentration decreased in the cell for 
production of more than six hours. Therefore, an induction of gene expression with 
400 µM imidazole for six hours at an incubation temperature of 25 °C was found 
optimal with less degradation of the protein. Recombinant UROD was produced 
with an  
N-terminal His10-tag. The resulting fusion proteins were purified to apparent 
homogeneity in a single step via affinity chromatography with a Ni2+-NTA affinity 
column using an ÄKTA PurifierTM. After washing and pre-elution with a linear rising 
imidazole gradient unspecific bound proteins were separated (Figure 3.2, lanes 3-
5). Soluble recombinant UROD was eluted with a final concentration of 250 mM 
imidazole. Following SDS-PAGE analysis of the purification procedure of wild type 
UROD revealed a dominant protein band which corresponded to a protein with a 
relative molecular mass of approximately 40,000 (Figure 3.2, lanes 6-11). This is 
in good agreement with the calculated molecular mass of the fusion protein of 
43,300. 
The UROD mutant variants demonstrated similar purification results like the wild 
type UROD (data not shown). About 8 mg of recombinant protein per litre cell 
culture were obtained. Since the presence of the histidine tag was shown to have 
no influence of enzymatic activity (Phillips et al., 1997) there was no necessity for 
histidine tag removal. Further, in this study it was proofed that UROD did not show 
detectable degradation when stored at 4 °C for a time period of more than a 
month.  
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x 1000 Figure 3.2: Production, 
purification and processing of 
recombinant human uro-
porphyrinogen III decarboxylase 
produced in E. coli. 
Proteins were separated by 12 % 
SDS-PAGE and visualised by 
staining with InstantBlue. Lane 1: 
molecular weight marker; lane 2: 
total soluble protein extract after 
induction of gene expression with 
400 µM IPTG for 6 h at 25 °C; 
lanes 3-5: washing steps; lanes 6-
11: purified UROD eluted with 
250 mM imidazole. 
 
 
3.1.2 Catalytic Relevance of Arginine 
 
The recombinantly produced wild type UROD and its constructed variants R37A, 
R37K, R41A and R41K, respectively, were tested for catalysis. Therefore, a 
UROD activity assay was carried out under standard conditions after a procedure 
as described earlier (Phillips and Kushner, 1999). All procedures were performed 
under strict anaerobic conditions. After incubation at 37 °C in the dark for 30 min 
the reaction was stopped by addition of concentrated hydrochloric acid. Formed 
coproporphyrinogen III was oxidized for 15 min to coproporphyrin III by addition of 
H2O2. Subsequently, formed coproporphyrin III was detected by HPLC analysis 
using an excitation wavelength of 409 nm and an emission wavelength of 618 nm 
for fluorescence measurement. Uroporphyrin III and coproporphyrin III with known 
concentrations were used as standards. The Uroporphyrin III and 
coproporphyrin III concentrations present in the samples were calculated via a 
calibration curve.  
Wild type UROD activity resulted in the conversion into the colourless 
coproporphyrinogen III which was further converted into coproporphyrin III by 
H2O2 for HPLC analysis. Fluorescence emission peaks for standards of 
uroporphyrin III and coproporphyrin III were detected with retention times of 
approximately 10 min for uroporphyrin III and approximately 37 min for 
coproporphyrin III. Wild type UROD demonstrated normal enzymatic activity in the 
substrate concentration range of 0.025-35 µM, meaning that uroporphyrinogen III 
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was converted into coproporphyrinogen III without formation of detectable reaction 
intermediates (Figure 3.3). 
 
-10
490
990
1490
1990
2490
2990
3490
0 10 20 30 40 50 60 7
retention time [min]
he
ig
ht
 in
 [µ
V]
0
0,025 µM 0,05 µM 0,1 µM 0,2 µM
 
Figure 3.3: Detection of substrate and products of wild type UROD by HPLC analysis. 
For analysis of UROD activity 20 µL reaction mixture were loaded on a reverse phase column for 
HPLC analysis. Tetrapyrroles were detected by fluorescence at an excitation wavelength of 409 nm 
and an emission wavelength of 618 nm. Standard curves revealed retention times of 10 min for 
uroporphyrin III and 37 min for coproporphyrin III. Wild type UROD demonstrates normal activity 
with different substrate concentrations meaning that uroporphyrinogen III was completely converted 
into the product coproporphyrinogen III. 
 
 
The wild type UROD activity increased to a substrate concentration of 
approximately 5-8 µM, after which activities decreased while higher substrate 
concentrations were obtained (Figure 3.4, curve mark ●). Subsequently, activity 
experiments comparing wild type and mutant UROD’s were performed in the same 
substrate range under the same conditions. In comparison with wild type UROD 
the mutant variant R37A showed enzymatic activity just at low substrate 
concentrations of 0.025-2 µM. However, in this range the R37A variant was just 
able to form small amounts of about 0.05 µM coproporphyrinogen III and failed in 
coproporphyrinogen III formation at higher substrate concentrations (Figure 3.4, 
curve mark ○). The UROD variants R37K and R41A did not show any enzymatic 
activity at all (data not shown). Here, neither coproporphyrinogen III nor reaction 
intermediates were detectable by HPLC analysis. 
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Figure 3.4: UROD activity comparison. 
Wild type and variants R37A, R37K, R41A and R41K, respectively, were tested for enzymatic 
catalysis activity. Wild type UROD (●) demonstrated normal enzymatic activity over a substrate 
concentration range of 0.025-35 µM, meaning that uroporphyrinogen III was converted into 
coproporphyrinogen III without formation of reaction intermediates. The activity increased until a 
substrate concentration of approximately 5-8 µM, after which activities reached a plateau. In 
comparison with wild type UROD the mutant variant R37A (○) showed enzymatic activity just at low 
substrate concentrations of 0.025-2 µM and failed in coproporphyrinogen III formation at higher 
substrate concentrations. UROD-R41K (ж) demonstrated enzymatic activity at small amounts of 
substrate concentration of 0.025-2 µM and reached a plateau of product formation at a substrate 
concentration of about 0.2-0.4 µM. Variants R37K and R41A showed enzymatic activity below the 
detection level (data not shown). 
 
 
In contrast, the R41K variant demonstrated enzymatic activity at small amounts of 
substrate concentration of 0.025-2 µM and reached a plateau of product formation 
at a substrate concentration of about 0.1-0.2 µM (Figure 3.4, curve marks ж). 
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Nevertheless, in this case coproporphyrinogen III as well as reaction intermediates 
were detectable (Figure 3.5). The attempt to identify the reaction intermediates by 
NMR analysis failed because of insufficient sample concentrations. 
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Figure 3.5: Catalysis of UROD mutant variant R41K: formation of intermediates analysed by 
HPLC analysis. 
 
Mutant variant R41K was just catalytically active at low substrate concentrations of about 0.025-
2 µM. In contrast to wild type and the other mutant variant R37A the product coproporphyrinogen III 
and additional reaction intermediates were detectable by HPLC analysis. 
 
 
3.1.3 Conclusions drawn from the Active Site Mutagenesis Studies of Human  
         Uroporphyrinogen III Decarboxylase 
 
The catalytic investigations of UROD mutant variants in comparison with the wild 
type enzyme led to the conclusion that the exchange of the positively charged 
amino acids Arg37 and Arg41 abolished enzyme activity. This proved the essential 
role of these residues in UROD catalysis and endorsed the density-functional 
calculations of the cooperation partner Petro Silva (University Fernando Pessoa at 
Porto, Portugal). The calculated models computed that pyrrole protonation rather 
than decarboxylation are the rate-limiting steps of the mechanism. According to 
the UROD crystal structure (Figure 3.6) these positively charged amino acid 
residues (mostly arginines, histidines and lysines) are important in the active site 
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cleft as interaction partners for the negatively charged substrate. These residues 
are thought to participate orientating the substrate directly or ameliorating the 
charge of the substrate binding pocket.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Crystal Stucture of human UROD 
Solved structure (Whitby et al., 1998) revealed a dimeric enzyme in which the two single domain 
subunits are orientated head-to-head with the active site clefts facing each other at the dimer 
interface arrangement of the two monomers. As a consequence, one large active site cleft is 
generated which is well shielded from the surrounding solvent, especially surrounding H3O+ ions. 
Recently, studies using a single chain dimeric UROD construct showed that substrate shuttling 
between the active sites is not required to generate coproporphyrinogen III (Phillips et al., 2009). 
The four central NH-groups of the tetrapyrrole are in hydrogen bounding distance to the highly 
conserved Asp86, which is proposed to be important for substrate stabilisation. Other positively 
charged residues (Arg37, Arg41, Arg50, Lys263, His220, His223 and His339) are important as 
interaction partners for the negatively charged substrate (modified after Layer et. al., 2010).  
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The solved structure of wild type human UROD (Whitby et al., 1998) revealed a 
dimeric enzyme in which the two single domain subunits are orientated head-to-
head with the active site clefts facing each other at the dimer interface 
arrangement of the two monomers. As a consequence, one large active site cleft 
is generated which is well shielded from the surrounding solvent, especially from 
the surrounding H3O+ ions. Moreover, it was shown that the arginine modifying 
reagent phenylglyoxal inactivated UROD function (Jones and Jordan, 1993). A 
further amino acid residue Asp86 had already been identified as an important 
residue for substrate stabilisation during catalysis (Phillips et al., 2003).  
Replacing an arginine with a lysine residue is a conservative exchange which may 
suggest that lysine is able to maintain the assumed ionic interaction of arginine 
with the substrate. However, substitution of Arg37 by lysine yielded into an inactive 
form of the enzyme. This suggested the very flexible basic amino acid residue 
Arg37 is lying close to the substrate and fulfilling the role of a general acid. Since 
lysine is a smaller amino acid than arginine, it was not expected to move close 
enough to the substrate to affect its protonation. However, it can still prevent 
decarboxylation of H3O+-protonated uroporphyrinogen III by stabilising its leaving 
carboxylate residue. Exchange of Arg37 by the non polar alanine residue 
surprisingly yielded a slightly active enzyme. This observation might be 
rationalised by invoking a mechanism whereby substrate binding to the mutant is 
much less effective due to the absence of the attracting Arg37. Thus, H3O+ ions 
might enter the enzyme active site cleft and protonates the substrate.  
The observed kinetic profile of the enzyme showed very peculiar features, which 
were consistent with the release of partially decarboxylated intermediates from the 
active site of the wild-type enzyme. At low substrate concentrations, these 
intermediates may get back into the active site and are rapidly converted into the 
product coproporphyrinogen III. At higher substrate concentrations, 
uroporphyrinogen III competes with these intermediates for entry into the active 
site and prevents them from finishing conversion into coproporphyrinogen III. 
However, the slow rate of decarboxylation in the presence of protonated Arg37 
allows the breaking of protonated uroporphyrinogen III to become a competitive 
reaction for the main catalytic path. In contrast, the use of Arg37 as a proton donor 
allows substrate protonation to occur while at the same time removing of the 
stabilising effect of protonated Arg37 on the leaving carboxylate proceeds.  
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The flexibility of Arg37, as well as its central position in the active site, allows this 
residue to donate the catalytic proton to every pyrrole ring in uroporphyrinogen III. 
This way Arg37 promotes the sequential decarboxylation of the acetic acid 
substituents on the intact substrate and on the partially decarboxylated 
intermediates without the need for different binding modes for each of these 
species. Since Arg37 is already in a protonated form at the physiological pH the 
reaction can take place by successive 90° rotation of the substrate in the active 
site. Simulation performed in cooperation with Silva also confirms that the proton 
provided by Arg37 may shuttle back and forth between the amino acid chain and 
each pyrrole ring allowing the sequential decarboxylation (Silva and Ramos, 
2005). The completion of each decarboxylation requires the transfer of an 
additional proton to the methylene substituent arising from CO2 release. Yet, the 
enzyme must shield its active site from solvent H3O+, which would be a second 
suitable alternative proton donor for this step.  
Examination of the crystal structure suggested that Arg41, the amino acid lying at 
the entrance to the active site, might be the proton donor for the reactions. Arg41 
is located at the protein surface, and therefore it is able to move widely, both 
towards the substrate and away from it. Re-protonation of Arg41, which would 
allow for the transfer of a new proton to the methylene formed in the reaction, is 
expected to occur readily. The location of Arg41 between the solvent and the 
active site allows this residue to react with H3O+ without the risk of substrate side 
reactions.  
The HPLC analysis of R41K mutant variant revealed low coproporphyrinogen III 
formation, but additional intermediates were detected. Although the intermediates 
were collected and subjected to NMR analysis, the chemical nature of these 
intermediates unfortunately could not be determined due to the low amounts. 
Lysine may be able to maintain the ionic interaction and is particularly able to 
coordinate the substrate in interaction with the residue Arg37. So, Arg37 is able to 
conduct catalysis. However, the Lys41 can not move close enough to the 
substrate to affect its protonation. Exchange the Arg41 to the non polar alanine 
residue resulted in prevention of the decarboxylation reaction. This suggests that 
the surface-located Arg41 undergoes conformational changes so that the 
substrate molecule can not be coordinated correctly in the active side cleft and 
Arg37 is not even able to be close enough for catalysis. 
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The results are also supported by former studies. There, the crystal structure of 
UROD in complex with the unnatural substrate uroporphyrinogen I revealed that 
the enzyme undergoes conformational changes and the flexible residue Arg41 
folds towards the enzyme surface (Phillips et al., 2003).  
The unusual use of two basic residues as general acids in two different proton 
donation steps in uroporphyrinogen III decarboxylase provides an elegant 
evolutionary adaptation. Thus, the problem of simultaneously binding the very 
negative uroporphyrinogen III in a positively charged active site and selectively 
protonating this substrate while preventing excessive carboxylate stabilisation by 
positive charges is excluded. These investigations revealed that minor changes in 
these two arginine residues cause adverse effects in the enzymatic catalysis. The 
interaction is important for substrate binding, coordination in the active site cleft 
and decarboxylation. 
 
 
3.2 Thermosynechococcus elongatus Haem Proteins 
 
Another object of this work was the investigation of the interaction and existence of 
protein complexes of different enzymes involved in early steps of tetrapyrrole 
biosynthesis. It is proposed that complex formation is necessary to avoid exposure 
of cell toxic biosynthesis intermediates. In former in vivo and in vitro studies of the 
terminal enzymes in the haem biosynthesis of the thermophilic cyanobacterium 
Thermosynechococcus elongatus it was already shown that the last two enzymes 
protoporphyrinogen IX oxidase and ferrochelatase form a complex to prevent 
release of the toxic intermediate protoporphyrin IX (Masoumi et al., 2008). 
Whereas, oxygen-dependent coproporphyrinogen III oxidase was not directly 
involved into this complex. Furthermore, T. elongatus porphobilinogen deaminase 
(PBGD), the third enzyme in the biosynthesis order, had already been 
characterised in our laboratory (Frese, 2008). First, in vitro investigations for the 
interaction between porphobilinogen deaminase and uroporphyrinogen III 
synthase (UROS) were already performed, using PBGD from T. elongatus and 
UROS from Bacillus megaterium, but precise answers are absent.  
In order to characterise the interaction or complex formation in T. elongatus the 
remaining haem biosynthesis enzymes porphobilinogen synthase (PBGS), 
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uroporphyrinogen III synthase (UROS), uroporphyrinogen III decarboxylase 
(UROD) and oxygen-independent coproporphyrinogen III oxidase (CPO) were 
object of this study. Therefore, the T. elongatus proteins were individually 
recombinantly produced and partly purified for antibody production for further 
interaction and complex formation studies. Furthermore, first activity studies had 
been performed.  
 
 
3.2.1 Cloning, Purification and Characterisation of Recombinant  
         Porphobilinogen Synthase  
 
The T. elongatus porphobilinogen synthase gene (hemB; EC 4.2.1.24) was cloned 
under the control of the T7-RNA-polymerase dependent promotor (Studier et al., 
1990) into the standard E. coli expression vector pET32a using the restriction sites 
EcoRI and NotI resulting in the construct pET32a-TEhemB. Several E. coli 
expression strains were tested at different incubation temperatures for 
recombinant protein production. The best conditions for recombinant PBGS 
production were obtained in E. coli Rossetta gami 2. PBGS was produced as 
fusion protein with a C-terminal His6-tag after induction of gene expression with 
400 µM isopropyl-β-D-thiogalactopyranoside (IPTG) at 37 °C over night. The cell-
free extract was loaded on a Ni2+-NTA affinity chromatography column and PBGS 
was purified to apparent homogeneity in a single step using an ÄKTA PurifierTM. 
Figure 3.7 provides documentation a SDS-PAGE of the purification procedure. 
After washing and pre-elution with a linear rising imidazole gradient unspecific 
bound proteins were separated. Soluble recombinant PBGS was eluted with a final 
concentration of 200 mM imidazole (Figure 3.7, lanes 13-15).  
SDS-PAGE analysis of the purified protein revealed a single band corresponding 
to a protein with a relative molecular mass of approximately 55,000 (Figure 3.7; 
lanes 13-15). This is in good agreement with the calculated molecular mass of the 
fusion protein of 50,800. A protein concentration of about 8 mg/mL of 
recombinantly purified PBGS was obtained. PBGS did not show detectable 
degradation at 4 °C for more than three months. 
 
- 59 - 
Results and Discussion 
 
 
 
PBGS is the second enzyme in the biosynthesis and catalyses the asymmetric 
condensation of two aminolaevulinic acid molecules to form porphobilinogen. To 
determine enzymatic activity of purified recombinant PBGS in vitro a modified 
Ehrlich’s test was performed under standard conditions as described in 
MATERIALS AND METHODS using a final concentration of PBGS of 10 µg/mL. 
Pseudomonas aeruginosa PBGS was used as positive control (Figure 3.8, tube 2) 
which was kindly provided by Ilka Heinemann (Heinemann, 2007). 
 
Figure 3.7: Production, 
purification and processing 
of recombinant T. elongatus 
porphobilinogen synthase 
produced in E. coli.  
Proteins were separated by 
12 % SDS-PAGE and 
visualised by staining with 
Coomassie Brilliant Blue. Lane 
1: molecular weight marker; 
lane 2: total cellular extract 
without induction of gene 
expression; lane 3: total cellular 
extract after overnight induction 
of gene expression with 400 µM 
IPTG; lanes 4-12: washing and 
pre-elution steps; lanes 13-15: 
purified PBGS after elution with 
200 mM imidazole. 
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1      2        3 Figure 3.8: Porphobilinogen synthase (PBGS) activity assay 
for the recombinant purified 
T. elongatus enzyme. 
The assay was carried out as 
described in MATERIALS AND 
METHODS. Tube 1: negative 
control; tube 2: positive control, 
P. aeruginosa PBGS; tube 3: 
T. elongatus PBGS.  The activity 
test was carried out at 45 °C for 
1 h. Tube 2 and 3 are showing a 
visible pink colouring, which is the 
result of complex formation 
between the reaction product 
porphobilinogen and 4-
(dimethylamino)-benzaldehyde.   
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Formed porphobilinogen was verified by complex formation with  
4-(dimethylamino)-benzaldehyde at an absorbance at 555 nm. Both T. elongatus 
PBGS and P. aeruginosa PBGS already showed visible pink colouring in the 
reaction tube at an incubation temperature of 45 °C (Figure 3.8). Since it is known 
that proteins of thermophilic bacteria are stable and enzymatic catalytic at high 
temperatures (Ladenstein and Antranikian, 1998) and the optimal growth-
temperature of the thermophilic T. elongatus is 55-60 °C (DSMZ, Braunschweig, 
Germany), the activity test was also performed at 55 °C. In this case the 
T. elongatus PBGS showed a slightly increase in activity but the P. aeruginosa 
PBGS lost strikingly activity. On the other hand an incubation temperature of 
37 °C, which is optimal for P. aeruginosa PBGS, decreased significantly the 
activity of T. elongatus PBGS (data not shown). With the obtained results it was 
possible to demonstrate optimal conditions for T. elongatus PBGS production and 
purification. Furthermore first investigations of T. elongatus PBGS activity were 
performed providing the first step towards further biochemical and structural 
investigations. 
 
 
3.2.2 Cloning, Production and Purification of Recombinant  
         Uroporphyrinogen III Synthase 
 
Initial investigations to study the interaction between UROS and PBGD were 
performed by Frederike Frese during her diploma thesis in our laboratoury. 
Therefore, PBGD from T. elongatus and UROS from B. megaterium were used for 
interaction studies via co-immunoprecipitation. T. elongatus UROS was also 
cloned into an expression vector, but unfortunately the produced protein degraded 
during cell disruption. Consequently, another approach was attempted to find an 
expression system to produce UROS from T. elongatus without degradation.   
In our group solid experiences have been made using B. megaterium for protein 
production over the years (Biedendieck et al., 2007). B. megaterium demonstrated 
high plasmid stability and does not possess any alkaline proteases degrading 
recombinant proteins (Kim, 2003). Additionally, it has been shown that protein 
production in B. megaterium is sensitive to the codon usage of the target gene 
(Yang et al., 2007). For that reason, the T. elongatus hemD DNA sequence was 
optimised for protein production in B. megaterium using the program JCAT 
- 61 - 
Results and Discussion 
(www.jcat.de; Grote et al., 2005). The correlation of the codon occurrence within 
the target gene and the preferred codons of the host are indicated as the “codon 
adaptation index” (CAI). This value can range from 0 (no similarity) to 1 (identical 
codon usage). It was found that genes with a CAI below 0.3 are not expressed in 
significant amounts in B. megaterium (Bäumchen et al., 2007; Yang et al., 2007). 
The original T. elongatus hemD DNA sequence showed a CAI of 0.29. The 
optimised hemD gene was generated by GeneArt (Regensburg, Germany) with a 
new calculated CAI of 0.85. The synthetic gene still encodes the original amino 
acid sequence of T. elongatus UROS. The synthetic gene was inserted into two 
different expression vectors. BglII and SphI restriction sites were used for pN-HIS-
TEV1622 (encoding an N-terminal His6-tag) and SpeI and SphI were used for 
pKMBm4 into which an additional His6-tag was cloned as described in 
MATERIALS AND METHODS (Biedendieck et al., 2007; Stammen et al., 2010). 
Both constructs produced a fusion protein with an N-terminal His6-tag and were 
sequenced for verification. Protoplasts of B. megaterium MS941 were transformed 
and analysed for recombinant protein production after induction of gene 
expression with 0.5 % xylose. Samples of proteins were taken from the cultures 3, 
4, 5 and 15 hours after induction at 37 °C. The intracellular proteins were 
separated into soluble and insoluble fractions and were analysed by SDS-PAGE. 
Two clones of B. megaterium containing pN-HIS-TEV1622-hemD were analysed 
for recombinant protein production of UROS by SDS-PAGE. Analysis of soluble 
proteins (Figure 3.9) revealed no visible production of UROS which would be 
recognised by a band corresponding to a protein with a calculated relative 
molecular mass of 54,000. In analysis of the insoluble proteins no visible 
production of UROS could be determined either (data not shown). 
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Additionally, Western blot analysis of the soluble and insoluble proteins was 
performed to verify the results using a primary anti His6-tag antibody from mouse 
and a secondary anti mouse antibody coupled to an alkaline phosphatase. 
Induction with NBT and BCIP led to visualisation of two soluble proteins (Figure 
3.10). The detected protein with an approximately molecular mass of 35,000 is 
known to be the B. megaterium host protein CbiX (Leech et al., 2003). CbiX is the 
sirohydrochlorin cobaltochelatase (EC 4.99.1.3) which is necessary for vitamin B12 
biosynthesis and includes a natural His6 amino acid sequence. Therefore, CbiX is 
always detectable in small amounts in the B. megaterium cell. The protein band 
corresponding to a protein with an approximately molecular mass of 40,000 should 
be the expected recombinantly produced UROS. Unfortunately, this does not 
correspond to the calculated relative molecular mass of the fusion protein of 
54,000.  
 
Figure. 3.9: Production of recombinant T. elongatus uroporphyrinogen III synthase in 
B. megaterium. 
Two B. megaterium clones containing pN-HIS-TEV1622-hemD were analysed for protein 
production. Proteins were separated by 12 % SDS-PAGE and visualised by staining with 
Coomassie Brilliant Blue. Lane 1: molecular weight marker; lane 2: total cellular extract without 
induction of gene expression; lanes 3-6: total soluble protein of B. megaterium clone 1 after 3, 4, 5 
and 15 hours induction of gene expression with 0.5 % xylose. Lanes 7-10: total soluble protein of 
B. megaterium clone 2 after 3, 4, 5 and 15 hours induction of gene expression with 0.5 % xylose. 
SDS-PAGE analysis revealed no protein production which would be recognised by an additional 
band with a calculated approximately molecular mass of 54,000. 
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The succeeding analysis of the hemD gene by sequencing did not reveal mutation 
of the gene or frame shift in the in the expression vector. Again the fusion protein 
seemed to be instable or degraded in the cell maybe because of its toxicity to 
B. megaterium. Nevertheless, the cell-free extract was purified using a Ni2+-NTA 
affinity chromatography column and subsequently loaded onto a gel-permeation 
column in an attempt to separate the two remaining proteins CbiX and “UROS” by 
size. After the two purification steps SDS-PAGE and Western blot analyses 
revealed that the protein concentration decreased extremely and no obvious 
separation could be observed (data not shown). Another approach was to 
separate the two proteins by heating the protein containing solution to 70 °C for 
20 min. Since T. elongatus proteins are stable at high temperatures (Ladenstein 
and Antranikian, 1998), the host’s CbiX protein should degrade while UROS stays 
soluble. Anyway, again Western blot analysis illustrated failure of this approach. 
Figure 3.10: Western blot analysis of the production of recombinant T. elongatus 
uroporphyrinogen III synthase in B. megaterium. 
Two B. megaterium clones were analysed for protein production by Western blot analysis. 
Proteins were detected with a primary anti His6-tag mouse antibody followed by an anti mouse 
antibody coupled to an alkaline phosphatase. Induction with NBT and BCIP led to visualisation 
of proteins. Lane 1: molecular weight marker; lane 2: total cellular extract without induction of 
gene expression; lanes 3-6: total soluble protein of B. megaterium clone 1 after 3, 4, 5 and 15 
hours induction of gene expression with 0.5 % xylose. Lanes 7-10: total soluble protein of 
B. megaterium clone 2 after 3, 4, 5 and 15 hours induction of gene expression with 0.5 % 
xylose. Two protein bands were detected. The lower approximately 35,000 protein is known to 
be the homolog protein CbiX of B. megaterium which includes a His6 amino acid sequence. The 
upper detected protein with approximately 40,000 should be the expected recombinantly 
produced UROS. 
x 1000  1       2        3         4        5         6         7        8        9        10 
100 
 
70 
 
 
55 
 
40 
 
 
35 
 
 
25 
- 64 - 
Results and Discussion 
The other expression vector pKMBm4-hemD was tested in B. megaterium for 
recombinant UROS production according to the previous analysis of vector 
construct pN-HIS-TEV1622-hemD. SDS-PAGE analysis of soluble and insoluble 
proteins revealed no visible production of UROS (data not shown). Finally, 
Western blot analysis only showed the CbiX protein while UROS was not 
detectable, although gene analysis was proper by sequencing (data not shown). 
So, the already suitable vector pGEX-6P-1 containing the T. elongatus hemD gene 
(Frese, 2008) was used for an approach for protein production. Therefore, the use 
of different E. coli bacterial strains was endeavoured to solve the problem of 
protein degradation during cell growth. After testing several E. coli strains the best 
result of recombinant protein production were obtained in E. coli Rossetta 
(DE3)pLysS. Induction of protein production with 400 µM isopropyl-β-D-
thiogalactopyranoside (IPTG) led to successful recombinant production at 25 °C of 
the N-terminal glutathione-S-transferase-tag (GST) fusion protein UROS. SDS-
PAGE analysis of the cell-free extract and the cell extract revealed an 
overproduction of a protein with a relative molecular mass of approximately 70,000 
(Figure 3.11; lane 4). This is in good agreement with the calculated molecular 
mass of the fusion protein UROS of 78,000. However, the overproduced protein 
UROS was found exclusively in the insoluble cellular extract.  
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x 1000  1      2       3       4     Figure 3.11: Production and solubility of 
recombinant T. elongatus uroporphyrinogen 
III synthase (UROS) produced in E. coli. 
Proteins were separated by 12 % SDS-PAGE 
and visualised by staining with InstantBlue. 
Lane 1: molecular weight marker; lane 2: total 
cellular extract without induction of gene 
expression; lane 3: total soluble protein after 
overnight induction of gene expression with 
400 µM IPTG; lane 4: total cellular extract after 
overnight induction of gene expression with 
400 µM IPTG. Lane 4 shows a additional 
protein with an approximately molecular mass 
of 70,000. 
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Approaches to solubilise the protein by adding detergents like CAPS, TritonX-100, 
Tesit or octyl glucoside in concentrations of about 0.2 up to 2 % to the lysis buffer 
and repeatedly disruption of the cell extract did not show improvement. All 
attempts to recombinantly produce soluble UROS in other E. coli production 
strains by induction with different IPTG concentrations at varying incubation 
temperatures in diverse time intervals failed. If protein production was obtained, 
different buffers for cell lyses in a pH range of 6.8 up to 8.0 were tested, as well as 
using expression vectors with other affinity-tags.  
 
 
3.2.3 Cloning, Production and Purification of Recombinant  
         Uroporphyrinogen III Decarboxylase and Recombinant Oxygen-  
         Independent Coproporphyrinogen III Oxidase 
 
The T. elongatus uroporphyrinogen III decarboxylase gene (hemE; EC 4.1.1.37) 
and the oxygen-independent coproporphyrinogen III oxidase gene (hemN; EC 
1.3.3.3) were cloned under the control of the T7-RNA-polymerase promotor into 
standard E. coli expression vectors. The hemE gene was inserted into pET32a 
with the restriction sides EcoRI and NotI, resulting in a fusion protein with a  
C-terminal histidine-tag. While the hemN gene was cloned into pGEX-6P-1 with 
the restriction sides EcoRI and NotI, resulting in a fusion protein with an N-terminal 
glutathione-S-transferase-tag (GST). Several E. coli strains were tested for 
recombinant protein production. Induction of protein production with 400 µM 
isopropyl-β-D-thiogalactopyranoside (IPTG) led to successful recombinant 
production of the C-terminal histidine-tagged fusion protein 
uroporphyrinogen III decarboxylase (UROD) in the E. coli strain Rossetta gami 2. 
Recombinant oxygen-independent coproporphyrinogen III oxidase (CPO) was 
produced in E. coli Rossetta (DE3)pLysS as a fusion protein with a N-terminal 
GST-tag by induction with 400 µM IPTG. 
Samples of protein were taken from the cultures 5, 6, 7 and 20 hours after 
induction at 25 °C. SDS-PAGE analysis of cell-free extract and cell extract of both 
proteins revealed in each case an overproduction of a protein that is 
corresponding to a relative molecular mass of approximately 55,000 (UROD; 
Figure 3.12, lane 5) and 80,000 (CPO; Figure 3.12, lane 3) after 20 hours. This is 
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in good agreement with the calculated molecular mass of the fusion protein UROD 
of 53,000 and CPO of 77,000. 
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Figure 3.12: Production and solubility 
of recombinant T. elongatus 
uroporphyrinogen III decarboxylase 
(UROD) and oxygen-independent 
coproporphyrinogen III oxidase (CPO) 
produced in E. coli. 
Proteins were separated by 12 % SDS-
PAGE and visualised by staining with 
InstantBlue. Lane 1: molecular weight 
marker; lane 2: total soluble protein after 
overnight induction of gene expression 
with 400 µM IPTG for CPO production; 
lane 3: total cellular extract after overnight 
induction of gene expression with 400 µM 
IPTG for CPO; lane 4: total soluble protein 
after overnight induction of gene 
expression with 400 µM IPTG for UROD 
production; lane 3: total cellular extract 
after overnight induction of gene 
expression with 400 µM IPTG for UROD. 
An additional dominant protein band is 
visible in lane 3 for CPO with an 
approximately relative molecular mass of 
80,000 and in lane 5 for UROD with an 
approximately relative molecular mass of 
55,000, respectively. 
 
 
 
 
However, both overproduced proteins were found exclusively in the insoluble 
cellular extracts (UROD: Figure 3.12, lane 5; CPO: Figure 3.12 lane 3). In order to 
solubilise UROD and CPO, the insoluble fractions and cell debris of E. coli were 
suspended in lysis buffer containing additionally detergents, like CAPS, TritonX-
100, Tesit or octyl glucoside ranging from 0.2-2 %, and repeatedly disruption of the 
cell extract revealed different results. In case of UROD following SDS-PAGE 
analysis did not show improvement (data not shown). The test solubility of CPO 
with additionally TritonX-100 was increased in small amount but led to degradation 
of the protein (data not shown) within 24 hours, so no purification procedure was 
practicable. First investigations to produce recombinant soluble UROD and CPO 
using other E. coli production strains by induction with different IPTG 
concentrations at varying incubation temperatures in diverse time intervals failed. 
When protein production was obtained, different buffers for cell lyses in a pH 
range of 6.8 up to 8.0 were tested, as well as using expression vectors with other 
affinity-tags. All strategies did not show any success. 
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4 SUMMARY 
 
During haem biosynthesis uroporphyrinogen III decarboxylase (UROD) catalyses 
the successive decarboxylation of uroporphyrinogen III acetate subunits to form 
coproporphyrinogen III. Dysfunction of this enzyme causes the disease porphyria 
cutanea tarda in humans.  
Based on amino acid sequence comparison of human UROD with UROD from 
other organisms, the crystal structure of human UROD (Whitby et al., 1998) and 
recently newly density-functional studies of the mechanism, two highly conserved 
arginine residues were proposed to be important for catalysis. Therefore, the 
arginine 37 and 41 residues of human UROD were exchanged by site-directed 
mutagenesis to investigate their functional role. Wild type and mutant UROD were 
recombinantly produced in E. coli, purified and biochemically characterised. The 
enzymatically influence of these residues were determined by analysing the 
UROD activity assay mixture by HPLC analysis. 
It could be shown that the exchange of the positively charged amino acids Arg37 
and Arg41 abolish the enzyme activity of UROD. The necessity of the interaction 
of these two arginine residues for substrate binding, coordination in the active site 
cleft and decarboxylation was demonstrated. 
 
A second part of this thesis focused on interactions and existence of protein 
complexes of different enzymes involved into early steps of tetrapyrrole 
biosynthesis in Thermosynechococcus elongatus. For the protection of highly cell-
toxic tetrapyrrole intermediates in the biosynthesis, it is proposed that the involved 
enzymes form complexes to channel the intermediates.  
Here T. elongatus hemB (PBGS), hemE (UROD) and hemN (CPO) were cloned 
into expression vectors. These proteins and an already existing cloned hemD 
gene (UROS) were recombinantly produced in E. coli. PBGS was successfully 
chromatographically purified and enzymatic activity could be revealed. However, 
the overproduced protein UROS, UROD and CPO were found exclusively in the 
insoluble cellular extract. Initial approaches to solubilise the protein were 
performed. 
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5 OUTLOOK 
 
Characterisation of human Uroporphyrinogen III Decarboxylase: 
 
The results of this work let conclude that the exchange of the positively charged 
amino acids Arg37 and Arg41 abolishes enzyme activity. The interaction of this 
two arginine residues are important for substrate binding, coordination in the active 
site cleft and decarboxylation, respectively.  
Further studies using molecular analysis could be performed in order to reveal the 
residues importance.  
 
1.) Mutagenesis studies of Arg37, Arg41 and Asp86 (human numbering) in 
other organism’s UROD. 
2.) Co-crystallisation experiments of the human mutant variants R37A, R37K, 
R41A and R41K with its substrate uroporphyrinogen III or product 
coproporphyrinogen III in order to study the UROD conformation and the 
substrate and/or product coordination in the active site cleft. 
 
 
Thermosynechococcus elongatus Haem Proteins: 
 
 
Porphobilinogen Synthase (PBGS): 
 
In this study it was possible to develop recombinant porphobilinogen synthase 
production, purification and initial corresponding activity. These were the first steps 
towards characterisation.  Further studies have to be carried out to determine its 
features more closely. 
 
1.) Determination of kinetic parameters, optimal temperature and pH 
dependence. 
2.) Investigation on the oligomeric state of the native protein. 
3.) Screening for stereochemical derivatives of alaremycin as potential PBGS 
inhibitors that specifically inhibit exclusively bacterial PBGS. 
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Uroporphyrinogen III Synthase, Uroporphyrinogen III Decarboxylase & Oxygen-
independent Coproporphyrinogen III Oxidase: 
 
In this study it was possible to develop recombinant enzyme production. However, 
all three enzymes were insoluble. It is necessary to perform further investigations 
towards the protein solubility.  
Additionally, following investigations should be performed: 
 
1.) Co-cloning of uroporphyrinogen III synthase with porphobilinogen 
deaminse, which may stabilise the protein and support correct folding of 
uroporphyrinogen III synthase. 
2.) Recombinant production of uroporphyrinogen III decarboxylase and 
coproporphyrinogen III oxidase in Bacillus megaterium or co-cloning into 
the same expression vector, to stabilise the protein and support protein 
folding. 
3.) Another attempt to yield soluble coproporphyrinogen III oxidase could be 
strict anaerobic conditions during cells disruption and purification. 
 
All four proteins should be studied to determine their features more closely.  
 
1.) Determination of kinetic parameters, optimal temperature and pH 
dependence. 
2.) Investigation on the oligomeric state of the native protein. 
3.) Crystallisation of T. elongatus proteins.  
4.) Antibody production for interaction and complex formation studies in vitro 
and in vivo. 
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